This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Other injuries of lower limb, level unspecified
ST19_OTHER_INJURI_LOWER_LIMB_LEVEL_UNSPE
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleNone |
519870 |
2. Check conditionsNone |
519870 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
382 |
4. Check minimum number of eventsNone |
382 |
5. Include endpointsNone |
382 |
6. Filter based on genotype QC (FinnGen only) |
369 |
Control definitions (FinnGen only)
- Control exclude
- ST19_INJURI_UNSPE_PART_TRUNK_LIMB_BODY_REGION
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- T0[8-9]|T1[0-4]
- Name in latin
- Aliae laesiones membri inferioris, regione non specificata
Similar endpoints
↥List of similar endpoints to
Other injuries of lower limb, level unspecified
based on the number of shared cases.
Similar with more cases:
- Injuries to unspecified part of trunk, limb or body region
- Injury, poisoning and certain other consequences of external causes
- Any prescribed medicine buy
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 369 | 204 | 165 |
| Unadjusted period prevalence (%) | 0.07 | 0.07 | 0.08 |
| Median age at first event (years) | 55.68 | 53.52 | 58.34 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 382
- Matched controls
- 3820
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
T13.1
ICD-10 Finland
Open wound of lower limb, level unspecified
1884.6
218.1
191
*
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
10.2
56.0
69
81
X59
ICD-10 Finland
Exposure to unspecified factor
4.7
46.4
152
467
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
10.1
44.8
54
61
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
12.3
43.2
45
41
T13.2
ICD-10 Finland
Dislocation, sprain and strain of unspecified joint and ligament of lower limb, level unspecified
156.8
40.6
42
*
T13.0
ICD-10 Finland
Superficial injury of lower limb, level unspecified
+∞
39.2
37
*
S97
ICPC
Chronic ulcer skin
6.4
37.8
70
129
T13.5
ICD-10 Finland
Injury of unspecified muscle and tendon of lower limb, level unspecified
+∞
36.0
34
*
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
8.9
31.3
41
51
T13.9
ICD-10 Finland
Unspecified injury of lower limb, level unspecified
+∞
28.5
27
*
X58
ICD-10 Finland
Exposure to other specified factors
3.9
28.1
105
341
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
3.0
23.9
170
807
T13.3
ICD-10 Finland
Injury of unspecified nerve of lower limb, level unspecified
+∞
22.1
21
*
A46
ICD-10 Finland
Erysipelas
3.3
19.8
88
314
W19
ICD-10 Finland
Unspecified fall
3.7
19.3
68
209
J01CF05
ATC
flucloxacillin; systemic
4.1
19.2
57
155
S18
ICPC
Laceration/cut
2.6
19.1
223
1323
W22
ICD-10 Finland
Striking against or struck by other object(s)
4.4
19.1
52
132
SPAT1148
SPAT
Treatment of chronic ulcer or burn
3.4
18.7
78
267
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.7
17.8
62
188
T13.4
ICD-10 Finland
Injury of unspecified blood vessel of lower limb, level unspecified
+∞
17.8
17
*
T36
ICD-10 Finland
Poisoning by systemic antibiotics
5.5
16.8
34
67
Z3226
NOMESCO Finland
Physiotherapist
2.8
15.8
101
439
J01FF01
ATC
clindamycin; systemic
2.5
15.5
131
652
R4110
NOMESCO Finland
Physiotherapy
2.5
15.4
140
721
Z3231
NOMESCO Finland
Registered nurse
2.5
15.2
139
718
ZXA05
NOMESCO Finland
Left side
2.6
14.9
118
568
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
4.6
14.9
37
87
ZXA00
NOMESCO Finland
Right side
2.5
14.9
128
641
M79.6
ICD-10 Finland
Pain in limb
2.3
14.8
206
1274
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.0
14.8
44
119
T13.8
ICD-10 Finland
Other specified injuries of lower limb, level unspecified
+∞
14.7
14
*
N02AJ06
ATC
codeine and paracetamol; systemic
2.3
14.5
202
1246
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
6.0
14.3
26
46
C03CA01
ATC
furosemide; systemic
2.4
14.3
137
719
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
3.7
14.1
49
148
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.9
13.7
74
292
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.7
13.2
88
387
S80.1
ICD-10 Finland
Contusion of other and unspecified parts of lower leg
5.0
13.1
29
62
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
3.9
13.0
40
111
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
2.9
12.9
69
271
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
12.8
108
532
N02AX02
ATC
tramadol; systemic, rectal
2.2
12.7
185
1144
AA1AD
NOMESCO Finland
CT of head and brain
2.3
12.2
128
691
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.6
12.2
82
362
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
3.4
12.1
46
147
N03AX16
ATC
[U] pregabalin
2.4
12.1
106
529
J01DB01
ATC
cefalexin; oral
3.0
12.1
335
2685
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
3.3
11.4
46
153
A28
ICPC
Limited function/disability NOS
2.5
11.3
88
415
S81.9
ICD-10 Finland
Open wound of lower leg, part unspecified
17.7
11.3
17
10
L28
ICPC
Limited function/disability (L)
2.4
11.1
90
432
W17
ICD-10 Finland
Other fall from one level to another
4.3
11.1
29
71
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.8
11.0
63
255
S91.3
ICD-10 Finland
Open wound of other parts of foot
5.6
11.0
21
39
B01AA03
ATC
warfarin; systemic
2.5
10.9
77
347
WX402
NOMESCO Finland
General anaesthesia
2.3
10.8
104
537
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.4
10.8
89
430
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
2.8
10.6
60
241
NG4AA
NOMESCO Finland
Lower leg X-ray examination
4.2
10.4
28
70
WX006
NOMESCO Finland
Intravenous sedation or analgesia without general anesthesia
3.4
10.2
39
125
NE1AA
NOMESCO Finland
Pelvis X-ray examination
3.1
10.2
44
152
NHQ40
NOMESCO Finland
Amputation of toe
11.7
10.2
18
16
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.1
9.8
113
625
B01AB05
ATC
enoxaparin; parenteral
2.1
9.8
134
792
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
8.2
9.8
21
27
TQW40
NOMESCO Finland
Remowal of suture of skin
3.3
9.7
39
129
ZXE00
NOMESCO Finland
One hour or less
2.0
9.5
164
1050
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.4
9.5
77
368
X57
ICD-10 Finland
Unspecified privation
5.4
9.5
19
37
M10.9
ICD-10 Finland
Gout, unspecified
3.2
9.1
38
129
L17
ICPC
Foot/toe symptom/complaint
2.0
9.0
135
819
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
3.2
9.0
36
119
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
4.0
8.9
26
69
Z71.8
ICD-10 Finland
Other specified counselling
1.9
8.8
155
993
ZXE10
NOMESCO Finland
More than one and less than three hours
2.0
8.8
146
918
TPH07
NOMESCO Finland
Cathetrisation of artery
2.6
8.7
55
233
TQW11
NOMESCO Finland
Vacuum treatment of wound
7.2
8.7
20
29
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.6
8.4
54
231
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
4.3
8.4
22
54
WX002
NOMESCO Finland
Sedation and analgesia
2.2
8.4
82
423
Z09.4
ICD-10 Finland
Follow-up examination after treatment of fracture
3.4
8.3
30
93
WX213
NOMESCO Finland
Lower leg blockade
14.9
8.3
13
9
M54.5
ICD-10 Finland
Low back pain
1.9
8.2
156
1020
X78
ICD-10 Finland
Intentional self-harm by sharp object
12.1
8.1
14
12
I50.9
ICD-10 Finland
Heart failure, unspecified
2.4
8.1
61
281
Y94.8
ICD-10 Finland
Other leisure activity accident
4.3
8.1
21
51
XF400
NOMESCO Finland
ECG with 12 standard connections
2.3
8.1
69
336
ZZA00
NOMESCO Finland
Split skin graft
4.8
8.0
18
39
R5110, ,
SPAT
2.7
7.9
43
169
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
4.2
7.9
21
52
E0000UV, ,
ATC
1.9
7.9
168
1135
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.8
7.9
186
1298
A01
ICPC
Pain general/multiple sites
2.5
7.8
51
220
A08
ICPC
Swelling
3.1
7.7
32
108
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.5
7.7
50
215
ZXE20
NOMESCO Finland
More than three and less than five hours
2.3
7.7
64
308
NA1AD
NOMESCO Finland
Cervical spine CT examination
3.5
7.7
27
82
ZXD05
NOMESCO Finland
Urgent procedure
1.9
7.6
126
783
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
10.3
7.6
14
14
WX320
NOMESCO Finland
Spinalanesthesy
2.0
7.6
105
615
S80.0
ICD-10 Finland
Contusion of knee
2.7
7.6
43
173
ZXA10
NOMESCO Finland
Bilateral
2.1
7.5
82
440
QDA10
NOMESCO Finland
Incision of skin of lower limb
13.7
7.4
12
9
H02AB06
ATC
prednisolone; systemic
1.8
7.4
185
1305
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.5
7.4
48
206
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.4
7.4
52
232
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
11.2
7.3
13
12
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
3.2
7.3
29
95
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.8
7.3
177
1236
H02AB04
ATC
methylprednisolone; systemic
2.3
7.3
60
287
Z2221
NOMESCO Finland
Medical doctor
1.9
7.2
117
720
N06AX11
ATC
mirtazapine; oral
1.8
7.1
141
924
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
4.0
7.1
20
52
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
6.5
7.0
17
27
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.6
7.0
43
180
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
3.7
7.0
22
62
D07AD01
ATC
clobetasol; topical
2.2
7.0
68
349
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
3.5
6.9
24
72
QDB10, ,
SPAT
4.2
6.9
18
44
K78
ICPC
Atrial fibrillation/flutter
2.8
6.9
34
127
R60.0
ICD-10 Finland
Localized oedema
2.3
6.8
57
274
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.2
6.8
58
282
WX408
NOMESCO Finland
General anesthesy, balanced
1.9
6.8
103
620
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.7
6.8
38
152
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
6.7
181
1295
V01.9
ICD-10 Finland
Pedestrian injured in collision with pedal cycle, Unspecified whether traffic or nontraffic accident
23.0
6.7
9
*
I48
ICD-10 Finland
Atrial fibrillation and flutter
2.0
6.7
78
428
T79.3
ICD-10 Finland
Post-traumatic wound infection, not elsewhere classified
6.1
6.7
17
29
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.0
6.6
29
101
QDB00
NOMESCO Finland
Suture of skin of lower limb
12.5
6.6
11
9
J01MA02
ATC
ciprofloxacin; systemic
1.8
6.6
147
995
I50.0
ICD-10 Finland
Congestive heart failure
2.8
6.5
34
131
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.4
6.5
44
193
D64.9
ICD-10 Finland
Anaemia, unspecified
2.4
6.5
47
213
X50
ICD-10 Finland
Overexertion and strenuous or repetitive movements
5.3
6.4
18
35
W10
ICD-10 Finland
Fall on and from stairs and steps
2.9
6.4
30
109
XF600
NOMESCO Finland
Bloodpressure measurement
2.8
6.3
32
121
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.9
6.3
84
483
207
Kela drug reimbursment
Chronic arrhythmias
2.2
6.2
57
285
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
3.0
6.2
27
94
J01DA09
ATC
[U] cefadroxil
1.9
6.2
101
621
NFQ20
NOMESCO Finland
Amputation of femur
12.8
6.1
10
8
ZXD35
NOMESCO Finland
Usual procedure
3.6
6.1
20
58
N03AX12
ATC
[U] gabapentin; oral
2.0
6.1
68
367
S71.1
ICD-10 Finland
Open wound of thigh
10.3
6.1
11
11
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.0
6.1
74
412
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.3
6.1
47
219
R06AE07
ATC
cetirizine; oral
1.7
6.0
164
1166
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.3
6.0
48
226
TimeCodeWAS
↥TODO / Current known limitations:
- Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
- Legend / how to read the glyphs.
- Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
- Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
- Download CSV.
- No filters and sorters.
- Limited amount of endpoints (~400) having TimeCodeWAS data.
- Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Chronic ulcer skin
S97 [2002001061]
S97 [2002001061]
1.4e+00
1.6e+00
2.4e+00
—
2.5e+00
2.6e+00
1.5e+00
cases:3.96%
controls:0.98%
cases:2.37%
controls:0.50%
cases:2.37%
controls:0.21%
—
—
cases:2.65%
controls:0.21%
cases:6.73%
controls:0.54%
cases:4.84%
controls:1.12%
15
37
364
3753
9
19
370
3771
9
8
370
3782
—
10
8
367
3763
23
19
319
3531
12
29
236
2551
Bacteria identified in Skin by Aerobe culture
620-5 [3007853]
620-5 [3007853]
1.4e+00
1.5e+00
2.1e+00
1.0e+50
3.7e+00
1.8e+00
1.0e+00
cases:11.35%
controls:2.96%
cases:4.49%
controls:1.08%
cases:2.11%
controls:0.26%
cases:3.96%
controls:0.00%
cases:5.84%
controls:0.16%
cases:6.43%
controls:1.15%
cases:7.66%
controls:2.87%
43
112
336
3678
17
41
362
3749
8
10
371
3780
15
0
364
3790
22
6
355
3765
22
41
320
3509
19
74
229
2506
Fall on same level from slipping, tripping and stumbling
W01 [45756243]
W01 [45756243]
9.4e-01
1.3e+00
2.6e+00
1.0e+50
3.6e+00
1.5e+00
9.5e-01
cases:10.82%
controls:4.54%
cases:6.60%
controls:1.90%
cases:3.17%
controls:0.24%
cases:9.76%
controls:0.00%
cases:5.57%
controls:0.16%
cases:7.60%
controls:1.86%
cases:15.32%
controls:6.51%
41
172
338
3618
25
72
354
3718
12
9
367
3781
37
0
342
3790
21
6
356
3765
26
66
316
3484
38
168
210
2412
Plastic And Reconstructive Surgery
24 [38004467]
24 [38004467]
9.0e-01
5.8e-01
2.3e+00
1.0e+50
4.0e+00
2.2e+00
1.4e+00
cases:7.12%
controls:3.03%
cases:2.11%
controls:1.19%
cases:1.85%
controls:0.18%
cases:4.75%
controls:0.00%
cases:8.22%
controls:0.16%
cases:9.36%
controls:1.10%
cases:9.27%
controls:2.56%
27
115
352
3675
8
45
371
3745
7
7
372
3783
18
0
361
3790
31
6
346
3765
32
39
310
3511
23
66
225
2514
Laceration/cut
S18 [2002000983]
S18 [2002000983]
5.8e-01
9.8e-01
3.0e+00
—
3.8e+00
1.5e+00
7.3e-01
cases:17.41%
controls:10.55%
cases:8.97%
controls:3.56%
cases:7.65%
controls:0.40%
—
—
cases:18.04%
controls:0.50%
cases:14.04%
controls:3.38%
cases:18.95%
controls:10.16%
66
400
313
3390
34
135
345
3655
29
15
350
3775
—
68
19
309
3752
48
120
294
3430
47
262
201
2318
Atherosclerosis of arteries of extremities
I70.2 [45538421]
I70.2 [45538421]
1.2e+00
1.7e+00
1.7e+00
—
2.5e+00
1.5e+00
1.7e+00
cases:5.28%
controls:1.64%
cases:3.96%
controls:0.71%
cases:2.11%
controls:0.40%
—
—
cases:3.98%
controls:0.34%
cases:4.68%
controls:1.10%
cases:6.45%
controls:1.28%
20
62
359
3728
15
27
364
3763
8
15
371
3775
—
15
13
362
3758
16
39
326
3511
16
33
232
2547
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1988-5 [3020460]
4.3e-01
5.4e-01
1.3e+00
4.5e+00
1.9e+00
5.2e-01
3.4e-01
cases:54.35%
controls:43.72%
cases:37.20%
controls:25.75%
cases:16.36%
controls:5.22%
cases:21.37%
controls:0.29%
cases:26.79%
controls:5.04%
cases:35.96%
controls:24.99%
cases:51.21%
controls:42.83%
206
1657
173
2133
141
976
238
2814
62
198
317
3592
81
11
298
3779
101
190
276
3581
123
887
219
2663
127
1105
121
1475
Ulcer of lower limb, not elsewhere classified
L97 [45591659]
L97 [45591659]
2.0e+00
2.4e+00
—
1.0e+50
—
2.4e+00
2.3e+00
cases:3.43%
controls:0.50%
cases:2.37%
controls:0.21%
—
—
cases:1.32%
controls:0.00%
—
—
cases:4.39%
controls:0.39%
cases:6.05%
controls:0.62%
13
19
366
3771
9
8
370
3782
—
5
0
374
3790
—
15
14
327
3536
15
16
233
2564
General Surgery
2 [38004447]
2 [38004447]
5.9e-01
1.3e+00
2.0e+00
1.0e+50
2.9e+00
1.6e+00
7.6e-01
cases:22.96%
controls:14.17%
cases:12.93%
controls:4.04%
cases:3.96%
controls:0.55%
cases:19.79%
controls:0.00%
cases:7.43%
controls:0.42%
cases:14.62%
controls:3.49%
cases:23.39%
controls:12.48%
87
537
292
3253
49
153
330
3637
15
21
364
3769
75
0
304
3790
28
16
349
3755
50
124
292
3426
58
322
190
2258
Bacteria identified in Blood by Culture
600-7 [3023368]
600-7 [3023368]
8.6e-01
1.1e+00
2.3e+00
—
2.5e+00
1.1e+00
1.0e+00
cases:15.30%
controls:7.12%
cases:8.44%
controls:2.90%
cases:3.17%
controls:0.34%
—
—
cases:4.51%
controls:0.37%
cases:8.19%
controls:2.85%
cases:16.53%
controls:6.82%
58
270
321
3520
32
110
347
3680
12
13
367
3777
—
17
14
360
3757
28
101
314
3449
41
176
207
2404
Nursing episode
950 [44777714]
950 [44777714]
9.2e-01
1.3e+00
1.9e+00
—
2.3e+00
1.2e+00
1.1e+00
cases:5.80%
controls:2.40%
cases:4.22%
controls:1.13%
cases:2.37%
controls:0.37%
—
—
cases:3.71%
controls:0.37%
cases:4.39%
controls:1.32%
cases:6.85%
controls:2.40%
22
91
357
3699
16
43
363
3747
9
14
370
3776
—
14
14
363
3757
15
47
327
3503
17
62
231
2518
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
30385-9 [3002385]
4.6e-01
6.4e-01
1.0e+00
4.4e+00
1.6e+00
5.7e-01
3.3e-01
cases:46.97%
controls:35.96%
cases:40.63%
controls:26.60%
cases:15.30%
controls:5.96%
cases:17.68%
controls:0.26%
cases:24.93%
controls:6.21%
cases:39.77%
controls:27.15%
cases:46.77%
controls:38.60%
178
1363
201
2427
154
1008
225
2782
58
226
321
3564
67
10
312
3780
94
234
283
3537
136
964
206
2586
116
996
132
1584
Mental and behavioural disorders due to use of alcohol, Harmful use
F10.1 [45595844]
F10.1 [45595844]
1.4e+00
2.6e+00
—
—
—
2.7e+00
1.8e+00
cases:2.90%
controls:0.71%
cases:2.11%
controls:0.16%
—
—
—
—
—
—
cases:2.05%
controls:0.14%
cases:4.44%
controls:0.74%
11
27
368
3763
8
6
371
3784
—
—
—
7
5
335
3545
11
19
237
2561
Physiotherapy
R4110 [2001310233]
R4110 [2001310233]
1.2e+00
1.3e+00
—
1.0e+50
3.0e+00
1.6e+00
1.4e+00
cases:15.04%
controls:5.20%
cases:6.60%
controls:1.90%
—
—
cases:2.64%
controls:0.00%
cases:4.77%
controls:0.24%
cases:6.73%
controls:1.44%
cases:14.11%
controls:3.88%
57
197
322
3593
25
72
354
3718
—
10
0
369
3790
18
9
359
3762
23
51
319
3499
35
100
213
2480
General Practice
1 [38004446]
1 [38004446]
9.0e-01
1.3e+00
1.9e+00
1.0e+50
2.6e+00
9.4e-01
8.1e-01
cases:28.76%
controls:14.14%
cases:15.83%
controls:5.04%
cases:4.75%
controls:0.74%
cases:12.14%
controls:0.00%
cases:9.81%
controls:0.80%
cases:14.04%
controls:5.97%
cases:28.63%
controls:15.16%
109
536
270
3254
60
191
319
3599
18
28
361
3762
46
0
333
3790
37
30
340
3741
48
212
294
3338
71
391
177
2189
Vascular Surgery
77 [38004496]
77 [38004496]
1.0e+00
1.3e+00
1.6e+00
1.0e+50
2.9e+00
1.7e+00
1.3e+00
cases:7.65%
controls:2.93%
cases:4.22%
controls:1.19%
cases:1.32%
controls:0.26%
cases:3.43%
controls:0.00%
cases:3.71%
controls:0.21%
cases:7.02%
controls:1.30%
cases:8.47%
controls:2.48%
29
111
350
3679
16
45
363
3745
5
10
374
3780
13
0
366
3790
14
8
363
3763
24
46
318
3504
21
64
227
2516
cefalexin; oral
J01DB01 [21602870]
J01DB01 [21602870]
7.4e-01
8.8e-01
2.0e+00
—
2.6e+00
1.1e+00
6.3e-01
cases:45.65%
controls:28.60%
cases:19.79%
controls:9.29%
cases:8.71%
controls:1.21%
—
—
cases:12.73%
controls:1.03%
cases:21.05%
controls:8.42%
cases:38.71%
controls:25.16%
173
1084
206
2706
75
352
304
3438
33
46
346
3744
—
48
39
329
3732
72
299
270
3251
96
649
152
1931
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
28540-3 [3003338]
3.2e-01
6.1e-01
1.1e+00
4.5e+00
1.7e+00
3.8e-01
3.6e-01
cases:48.55%
controls:40.66%
cases:41.16%
controls:27.49%
cases:16.36%
controls:5.94%
cases:17.41%
controls:0.24%
cases:24.40%
controls:5.75%
cases:35.67%
controls:27.55%
cases:47.18%
controls:38.49%
184
1541
195
2249
156
1042
223
2748
62
225
317
3565
66
9
313
3781
92
217
285
3554
122
978
220
2572
117
993
131
1587
Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 [40763571]
60517-0 [40763571]
8.4e-01
1.2e+00
1.9e+00
—
2.0e+00
9.5e-01
1.0e+00
cases:8.18%
controls:3.69%
cases:6.07%
controls:1.95%
cases:2.11%
controls:0.32%
—
—
cases:1.86%
controls:0.27%
cases:5.26%
controls:2.11%
cases:12.10%
controls:4.73%
31
140
348
3650
23
74
356
3716
8
12
371
3778
—
7
10
370
3761
18
75
324
3475
30
122
218
2458
Major dressing of wound of skin of lower limb
QDB10 [2001309970]
QDB10 [2001309970]
1.6e+00
1.7e+00
—
1.0e+50
—
3.8e+00
2.4e+00
cases:3.69%
controls:0.77%
cases:1.32%
controls:0.24%
—
—
cases:1.85%
controls:0.00%
—
—
cases:5.85%
controls:0.14%
cases:4.84%
controls:0.47%
14
29
365
3761
5
9
374
3781
—
7
0
372
3790
—
20
5
322
3545
12
12
236
2568
Transferrin [Mass/volume] in Serum or Plasma
3034-6 [3004789]
3034-6 [3004789]
7.7e-01
1.1e+00
1.9e+00
—
2.0e+00
1.0e+00
9.4e-01
cases:8.18%
controls:3.96%
cases:6.07%
controls:2.16%
cases:2.11%
controls:0.32%
—
—
cases:1.86%
controls:0.27%
cases:5.85%
controls:2.20%
cases:12.50%
controls:5.27%
31
150
348
3640
23
82
356
3708
8
12
371
3778
—
7
10
370
3761
20
78
322
3472
31
136
217
2444
Gas panel - Venous blood
24339-4 [3000991]
24339-4 [3000991]
1.2e+00
1.5e+00
—
—
2.7e+00
1.2e+00
1.0e+00
cases:7.12%
controls:2.35%
cases:4.49%
controls:1.03%
—
—
—
—
cases:1.86%
controls:0.13%
cases:3.51%
controls:1.04%
cases:7.66%
controls:2.95%
27
89
352
3701
17
39
362
3751
—
—
7
5
370
3766
12
37
330
3513
19
76
229
2504
Oxygen [Partial pressure] in Arterial blood
2703-7 [3027801]
2703-7 [3027801]
9.2e-01
1.6e+00
—
—
2.3e+00
1.5e+00
1.2e+00
cases:6.07%
controls:2.51%
cases:5.01%
controls:1.06%
—
—
—
—
cases:1.59%
controls:0.16%
cases:4.09%
controls:0.96%
cases:8.87%
controls:2.75%
23
95
356
3695
19
40
360
3750
—
—
6
6
371
3765
14
34
328
3516
22
71
226
2509
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]
2019-8 [3027946]
9.2e-01
1.6e+00
—
—
2.3e+00
1.5e+00
1.2e+00
cases:6.07%
controls:2.51%
cases:5.01%
controls:1.06%
—
—
—
—
cases:1.59%
controls:0.16%
cases:4.09%
controls:0.96%
cases:8.87%
controls:2.75%
23
95
356
3695
19
40
360
3750
—
—
6
6
371
3765
14
34
328
3516
22
71
226
2509
Orthopedic Surgery
20 [38004465]
20 [38004465]
6.1e-01
8.3e-01
1.4e+00
1.0e+50
2.5e+00
1.3e+00
8.5e-01
cases:26.12%
controls:16.12%
cases:14.51%
controls:6.86%
cases:4.49%
controls:1.16%
cases:11.08%
controls:0.00%
cases:8.75%
controls:0.80%
cases:19.30%
controls:5.89%
cases:29.44%
controls:15.16%
99
611
280
3179
55
260
324
3530
17
44
362
3746
42
0
337
3790
33
30
344
3741
66
209
276
3341
73
391
175
2189
pregabalin; oral
N02BF02 [955152]
N02BF02 [955152]
1.1e+00
1.3e+00
1.4e+00
—
1.7e+00
9.9e-01
1.0e+00
cases:10.29%
controls:3.64%
cases:6.60%
controls:1.93%
cases:3.17%
controls:0.79%
—
—
cases:3.71%
controls:0.72%
cases:5.85%
controls:2.25%
cases:10.08%
controls:3.95%
39
138
340
3652
25
73
354
3717
12
30
367
3760
—
14
27
363
3744
20
80
322
3470
25
102
223
2478
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
2823-3 [3023103]
2.8e-01
4.8e-01
1.2e+00
4.3e+00
1.5e+00
2.9e-01
4.1e-02
cases:53.83%
controls:46.83%
cases:45.12%
controls:33.72%
cases:18.21%
controls:6.23%
cases:19.53%
controls:0.34%
cases:24.14%
controls:6.52%
cases:40.35%
controls:33.72%
cases:48.39%
controls:47.36%
204
1775
175
2015
171
1278
208
2512
69
236
310
3554
74
13
305
3777
91
246
286
3525
138
1197
204
2353
120
1222
128
1358
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
2951-2 [3019550]
2.7e-01
4.7e-01
1.2e+00
4.3e+00
1.5e+00
3.0e-01
4.7e-02
cases:53.30%
controls:46.44%
cases:44.33%
controls:33.19%
cases:17.15%
controls:6.02%
cases:19.53%
controls:0.34%
cases:23.87%
controls:6.47%
cases:40.35%
controls:33.32%
cases:48.39%
controls:47.21%
202
1760
177
2030
168
1258
211
2532
65
228
314
3562
74
13
305
3777
90
244
287
3527
138
1183
204
2367
120
1218
128
1362
pH of Arterial blood
2744-1 [3019977]
2744-1 [3019977]
8.5e-01
1.6e+00
—
—
2.2e+00
1.5e+00
1.2e+00
cases:5.80%
controls:2.56%
cases:5.28%
controls:1.08%
—
—
—
—
cases:1.59%
controls:0.19%
cases:4.09%
controls:0.99%
cases:9.27%
controls:2.87%
22
97
357
3693
20
41
359
3749
—
—
6
7
371
3764
14
35
328
3515
23
74
225
2506
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
5894-1 [3033658]
9.7e-01
1.4e+00
—
1.0e+50
2.7e+00
1.2e+00
1.1e+00
cases:17.94%
controls:7.63%
cases:12.14%
controls:3.27%
—
—
cases:3.69%
controls:0.00%
cases:7.43%
controls:0.53%
cases:8.77%
controls:2.90%
cases:17.34%
controls:6.67%
68
289
311
3501
46
124
333
3666
—
14
0
365
3790
28
20
349
3751
30
103
312
3447
43
172
205
2408
Base excess in Arterial blood by calculation
1925-7 [3003396]
1925-7 [3003396]
8.7e-01
1.7e+00
—
—
2.2e+00
1.4e+00
1.2e+00
cases:5.80%
controls:2.51%
cases:5.28%
controls:1.06%
—
—
—
—
cases:1.59%
controls:0.19%
cases:4.09%
controls:1.01%
cases:8.87%
controls:2.83%
22
95
357
3695
20
40
359
3750
—
—
6
7
371
3764
14
36
328
3514
22
73
226
2507
Iron [Moles/volume] in Serum or Plasma
14798-3 [3022948]
14798-3 [3022948]
7.9e-01
1.0e+00
1.8e+00
—
1.9e+00
8.8e-01
8.8e-01
cases:8.97%
controls:4.30%
cases:6.07%
controls:2.24%
cases:2.11%
controls:0.34%
—
—
cases:1.86%
controls:0.29%
cases:5.85%
controls:2.51%
cases:12.50%
controls:5.58%
34
163
345
3627
23
85
356
3705
8
13
371
3777
—
7
11
370
3760
20
89
322
3461
31
144
217
2436
Emergency Medicine
93 [38004510]
93 [38004510]
5.2e-01
9.9e-01
2.3e+00
—
2.1e+00
7.3e-01
6.3e-01
cases:32.98%
controls:22.72%
cases:24.54%
controls:10.77%
cases:14.25%
controls:1.64%
—
—
cases:11.41%
controls:1.54%
cases:21.93%
controls:11.94%
cases:38.31%
controls:24.77%
125
861
254
2929
93
408
286
3382
54
62
325
3728
—
43
58
334
3713
75
424
267
3126
95
639
153
1941
Other extensive ultrasound examination of artery
PG1DE [2001309713]
PG1DE [2001309713]
2.3e+00
2.5e+00
—
—
—
—
2.4e+00
cases:3.69%
controls:0.37%
cases:1.58%
controls:0.13%
—
—
—
—
—
—
—
—
cases:2.82%
controls:0.27%
14
14
365
3776
6
5
373
3785
—
—
—
—
7
7
241
2573
Treatment of chronic ulcer or burn
SPAT1148 [2001700249]
SPAT1148 [2001700249]
8.1e-01
7.3e-01
2.3e+00
—
2.9e+00
1.9e+00
8.2e-01
cases:5.80%
controls:2.66%
cases:1.85%
controls:0.90%
cases:2.11%
controls:0.21%
—
—
cases:4.24%
controls:0.24%
cases:6.14%
controls:0.93%
cases:4.03%
controls:1.82%
22
101
357
3689
7
34
372
3756
8
8
371
3782
—
16
9
361
3762
21
33
321
3517
10
47
238
2533
codeine and paracetamol
N02AJ06 [1123647]
N02AJ06 [1123647]
5.7e-01
8.8e-01
1.8e+00
—
2.0e+00
1.1e+00
8.0e-01
cases:24.80%
controls:15.73%
cases:11.61%
controls:5.17%
cases:5.28%
controls:0.92%
—
—
cases:6.37%
controls:0.90%
cases:13.16%
controls:4.73%
cases:25.00%
controls:13.06%
94
596
285
3194
44
196
335
3594
20
35
359
3755
—
24
34
353
3737
45
168
297
3382
62
337
186
2243
Emergency Room Visit
ER [9203]
ER [9203]
8.4e-01
1.0e+00
1.3e+00
—
2.1e+00
1.1e+00
7.5e-01
cases:52.51%
controls:32.32%
cases:21.90%
controls:9.16%
cases:4.22%
controls:1.16%
—
—
cases:8.49%
controls:1.17%
cases:21.93%
controls:8.51%
cases:43.15%
controls:26.40%
199
1225
180
2565
83
347
296
3443
16
44
363
3746
—
32
44
345
3727
75
302
267
3248
107
681
141
1899
Hemoglobin [Mass/volume] in Arterial blood
30313-1 [3002173]
30313-1 [3002173]
8.6e-01
1.9e+00
—
—
2.3e+00
1.6e+00
1.2e+00
cases:4.75%
controls:2.06%
cases:5.28%
controls:0.82%
—
—
—
—
cases:1.59%
controls:0.16%
cases:3.80%
controls:0.79%
cases:8.06%
controls:2.52%
18
78
361
3712
20
31
359
3759
—
—
6
6
371
3765
13
28
329
3522
20
65
228
2515
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
62238-1 [40764999]
3.1e-01
5.3e-01
1.1e+00
4.0e+00
1.4e+00
3.0e-01
7.0e-02
cases:45.91%
controls:38.42%
cases:41.95%
controls:29.87%
cases:15.83%
controls:5.99%
cases:16.36%
controls:0.34%
cases:20.69%
controls:6.15%
cases:37.13%
controls:30.42%
cases:43.15%
controls:41.43%
174
1456
205
2334
159
1132
220
2658
60
227
319
3563
62
13
317
3777
78
232
299
3539
127
1080
215
2470
107
1069
141
1511
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
14682-9 [3020564]
1.8e-01
4.1e-01
1.1e+00
4.1e+00
1.4e+00
2.0e-01
3.2e-02
cases:55.41%
controls:50.82%
cases:48.55%
controls:38.44%
cases:20.32%
controls:7.78%
cases:19.53%
controls:0.40%
cases:25.46%
controls:8.06%
cases:43.86%
controls:38.99%
cases:52.82%
controls:52.02%
210
1926
169
1864
184
1457
195
2333
77
295
302
3495
74
15
305
3775
96
304
281
3467
150
1384
192
2166
131
1342
117
1238
Other specified counselling
Z71.8 [45581061]
Z71.8 [45581061]
8.5e-01
1.2e+00
1.6e+00
—
1.7e+00
1.0e+00
6.7e-01
cases:13.72%
controls:6.39%
cases:9.50%
controls:3.19%
cases:2.64%
controls:0.55%
—
—
cases:2.39%
controls:0.45%
cases:8.77%
controls:3.38%
cases:16.53%
controls:9.22%
52
242
327
3548
36
121
343
3669
10
21
369
3769
—
9
17
368
3754
30
120
312
3430
41
238
207
2342
Oxygen saturation in Arterial blood
2708-6 [3016502]
2708-6 [3016502]
8.2e-01
1.9e+00
—
—
2.3e+00
1.5e+00
1.2e+00
cases:5.01%
controls:2.27%
cases:4.75%
controls:0.77%
—
—
—
—
cases:1.59%
controls:0.16%
cases:3.80%
controls:0.85%
cases:8.47%
controls:2.71%
19
86
360
3704
18
29
361
3761
—
—
6
6
371
3765
13
30
329
3520
21
70
227
2510
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
30428-7 [3024731]
8.3e-02
3.7e-01
9.3e-01
4.1e+00
1.3e+00
2.2e-01
6.6e-02
cases:57.78%
controls:55.75%
cases:51.45%
controls:42.16%
cases:20.05%
controls:9.02%
cases:20.84%
controls:0.45%
cases:28.91%
controls:9.57%
cases:48.54%
controls:43.15%
cases:57.66%
controls:56.05%
219
2113
160
1677
195
1598
184
2192
76
342
303
3448
79
17
300
3773
109
361
268
3410
166
1532
176
2018
143
1446
105
1134
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
26453-1 [3026361]
8.2e-02
3.7e-01
9.2e-01
4.1e+00
1.3e+00
2.2e-01
6.6e-02
cases:57.78%
controls:55.78%
cases:51.45%
controls:42.24%
cases:20.05%
controls:9.10%
cases:20.84%
controls:0.45%
cases:28.91%
controls:9.60%
cases:48.54%
controls:43.15%
cases:57.66%
controls:56.05%
219
2114
160
1676
195
1601
184
2189
76
345
303
3445
79
17
300
3773
109
362
268
3409
166
1532
176
2018
143
1446
105
1134
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
718-7 [3000963]
7.7e-02
3.7e-01
9.1e-01
4.1e+00
1.3e+00
2.1e-01
8.2e-02
cases:57.78%
controls:55.88%
cases:51.45%
controls:42.30%
cases:20.05%
controls:9.13%
cases:20.84%
controls:0.45%
cases:28.91%
controls:9.68%
cases:48.54%
controls:43.27%
cases:58.06%
controls:56.05%
219
2118
160
1672
195
1603
184
2187
76
346
303
3444
79
17
300
3773
109
365
268
3406
166
1536
176
2014
144
1446
104
1134
Exposure to unspecified factor
X59 [45756412]
X59 [45756412]
1.2e+00
1.7e+00
—
1.0e+50
—
2.4e+00
1.2e+00
cases:7.92%
controls:2.64%
cases:3.43%
controls:0.66%
—
—
cases:16.09%
controls:0.00%
—
—
cases:6.14%
controls:0.56%
cases:8.47%
controls:2.64%
30
100
349
3690
13
25
366
3765
—
61
0
318
3790
—
21
20
321
3530
21
68
227
2512
Outpatient Visit
OP [9202]
OP [9202]
5.3e-01
3.1e-01
4.6e-01
3.6e+00
9.1e-01
7.0e-01
7.0e-01
cases:84.43%
controls:76.12%
cases:62.80%
controls:55.22%
cases:16.09%
controls:10.79%
cases:10.29%
controls:0.32%
cases:21.75%
controls:10.02%
cases:69.01%
controls:52.45%
cases:86.69%
controls:76.36%
320
2885
59
905
238
2093
141
1697
61
409
318
3381
39
12
340
3778
82
378
295
3393
236
1862
106
1688
215
1970
33
610
MCH [Entitic mass]
28539-5 [3035941]
28539-5 [3035941]
8.2e-02
3.5e-01
9.3e-01
4.1e+00
1.3e+00
2.2e-01
6.9e-02
cases:57.78%
controls:55.78%
cases:50.92%
controls:42.19%
cases:20.05%
controls:9.00%
cases:20.84%
controls:0.45%
cases:28.91%
controls:9.60%
cases:48.54%
controls:43.18%
cases:57.66%
controls:55.97%
219
2114
160
1676
193
1599
186
2191
76
341
303
3449
79
17
300
3773
109
362
268
3409
166
1533
176
2017
143
1444
105
1136
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
20570-8 [3009542]
8.2e-02
3.6e-01
9.2e-01
4.1e+00
1.3e+00
2.2e-01
6.6e-02
cases:57.78%
controls:55.78%
cases:51.19%
controls:42.27%
cases:20.05%
controls:9.08%
cases:20.84%
controls:0.45%
cases:28.91%
controls:9.60%
cases:48.54%
controls:43.18%
cases:57.66%
controls:56.05%
219
2114
160
1676
194
1602
185
2188
76
344
303
3446
79
17
300
3773
109
362
268
3409
166
1533
176
2017
143
1446
105
1134
Leukocytes [#/volume] in Blood
26464-8 [3010813]
26464-8 [3010813]
7.7e-02
3.6e-01
9.1e-01
4.1e+00
1.3e+00
2.1e-01
6.4e-02
cases:57.78%
controls:55.88%
cases:51.19%
controls:42.27%
cases:20.05%
controls:9.13%
cases:20.84%
controls:0.45%
cases:28.91%
controls:9.60%
cases:48.54%
controls:43.21%
cases:57.66%
controls:56.09%
219
2118
160
1672
194
1602
185
2188
76
346
303
3444
79
17
300
3773
109
362
268
3409
166
1534
176
2016
143
1447
105
1133
Platelets [#/volume] in Blood
26515-7 [3007461]
26515-7 [3007461]
8.6e-02
3.5e-01
9.2e-01
4.1e+00
1.3e+00
2.0e-01
6.9e-02
cases:57.78%
controls:55.67%
cases:50.92%
controls:42.19%
cases:20.05%
controls:9.05%
cases:20.84%
controls:0.45%
cases:28.65%
controls:9.60%
cases:48.25%
controls:43.18%
cases:57.66%
controls:55.97%
219
2110
160
1680
193
1599
186
2191
76
343
303
3447
79
17
300
3773
108
362
269
3409
165
1533
177
2017
143
1444
105
1136
Inpatient Hospital
21 [8717]
21 [8717]
6.3e-01
8.1e-01
1.3e+00
—
2.0e+00
9.0e-01
6.8e-01
cases:41.42%
controls:27.41%
cases:15.57%
controls:7.60%
cases:3.69%
controls:1.03%
—
—
cases:7.16%
controls:1.03%
cases:14.91%
controls:6.65%
cases:30.24%
controls:18.06%
157
1039
222
2751
59
288
320
3502
14
39
365
3751
—
27
39
350
3732
51
236
291
3314
75
466
173
2114
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]
40982-1 [3038288]
7.4e-01
1.0e+00
-1.0e+50
—
2.5e+00
1.6e+00
1.2e+00
cases:5.01%
controls:2.45%
cases:3.69%
controls:1.35%
cases:0.00%
controls:0.16%
—
—
cases:1.86%
controls:0.16%
cases:5.26%
controls:1.13%
cases:9.27%
controls:2.95%
19
93
360
3697
14
51
365
3739
0
6
379
3784
—
7
6
370
3765
18
40
324
3510
23
76
225
2504
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
890-4 [3001079]
4.2e-01
8.2e-01
1.7e+00
—
2.8e+00
8.7e-01
5.7e-01
cases:19.79%
controls:13.98%
cases:11.61%
controls:5.46%
cases:2.64%
controls:0.47%
—
—
cases:8.49%
controls:0.58%
cases:8.77%
controls:3.86%
cases:17.34%
controls:10.58%
75
530
304
3260
44
207
335
3583
10
18
369
3772
—
32
22
345
3749
30
137
312
3413
43
273
205
2307
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
2075-0 [3014576]
8.6e-01
1.5e+00
—
—
2.4e+00
1.3e+00
7.6e-01
cases:7.39%
controls:3.27%
cases:5.54%
controls:1.29%
—
—
—
—
cases:2.39%
controls:0.21%
cases:4.97%
controls:1.38%
cases:8.47%
controls:4.15%
28
124
351
3666
21
49
358
3741
—
—
9
8
368
3763
17
49
325
3501
21
107
227
2473
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
40987-0 [3043924]
7.5e-01
1.1e+00
-1.0e+50
—
2.3e+00
1.5e+00
1.2e+00
cases:5.01%
controls:2.43%
cases:3.96%
controls:1.37%
cases:0.00%
controls:0.16%
—
—
cases:1.86%
controls:0.19%
cases:5.26%
controls:1.18%
cases:9.68%
controls:3.26%
19
92
360
3698
15
52
364
3738
0
6
379
3784
—
7
7
370
3764
18
42
324
3508
24
84
224
2496
Home Visit
OMOP4822459 [581476]
OMOP4822459 [581476]
8.2e-01
1.1e+00
1.1e+00
1.2e+00
1.2e+00
1.1e+00
7.1e-01
cases:16.89%
controls:8.18%
cases:12.66%
controls:4.43%
cases:5.28%
controls:1.85%
cases:2.64%
controls:0.82%
cases:5.84%
controls:1.75%
cases:14.91%
controls:5.66%
cases:17.74%
controls:9.57%
64
310
315
3480
48
168
331
3622
20
70
359
3720
10
31
369
3759
22
66
355
3705
51
201
291
3349
44
247
204
2333
Bacteria identified in Isolate by Culture
43409-2 [3042936]
43409-2 [3042936]
1.2e+00
1.1e+00
2.2e+00
1.0e+50
—
1.6e+00
1.0e+00
cases:10.29%
controls:3.22%
cases:2.90%
controls:0.98%
cases:1.85%
controls:0.21%
cases:1.58%
controls:0.00%
—
—
cases:5.56%
controls:1.13%
cases:7.66%
controls:2.95%
39
122
340
3668
11
37
368
3753
7
8
372
3782
6
0
373
3790
—
19
40
323
3510
19
76
229
2504
furosemide; oral, parenteral
C03CA01 [21601518]
C03CA01 [21601518]
1.0e+00
1.0e+00
8.9e-01
—
9.0e-01
1.1e+00
1.0e+00
cases:17.68%
controls:7.15%
cases:15.04%
controls:6.02%
cases:5.28%
controls:2.24%
—
—
cases:5.31%
controls:2.23%
cases:16.37%
controls:6.11%
cases:20.16%
controls:8.26%
67
271
312
3519
57
228
322
3562
20
85
359
3705
—
20
84
357
3687
56
217
286
3333
50
213
198
2367
Emergency Room and Inpatient Visit
ERIP [262]
ERIP [262]
8.6e-01
1.3e+00
6.6e-01
—
2.0e+00
9.0e-01
7.5e-01
cases:18.21%
controls:8.60%
cases:14.25%
controls:4.43%
cases:1.32%
controls:0.69%
—
—
cases:6.10%
controls:0.88%
cases:11.70%
controls:5.10%
cases:21.77%
controls:11.59%
69
326
310
3464
54
168
325
3622
5
26
374
3764
—
23
33
354
3738
40
181
302
3369
54
299
194
2281
Case Management Agency
251B00000X [38004193]
251B00000X [38004193]
2.1e-01
2.3e-01
7.2e-01
4.1e+00
9.5e-01
1.7e-01
4.3e-02
cases:76.25%
controls:72.24%
cases:72.30%
controls:67.36%
cases:47.76%
controls:30.71%
cases:57.52%
controls:2.19%
cases:53.32%
controls:30.73%
cases:70.47%
controls:66.76%
cases:76.21%
controls:75.43%
289
2738
90
1052
274
2553
105
1237
181
1164
198
2626
218
83
161
3707
201
1159
176
2612
241
2370
101
1180
189
1946
59
634
Bicarbonate [Moles/volume] standard in Arterial blood
19230-2 [3014218]
19230-2 [3014218]
1.3e+00
1.5e+00
—
—
—
1.8e+00
1.2e+00
cases:3.43%
controls:1.00%
cases:2.37%
controls:0.53%
—
—
—
—
—
—
cases:2.63%
controls:0.45%
cases:6.05%
controls:1.90%
13
38
366
3752
9
20
370
3770
—
—
—
9
16
333
3534
15
49
233
2531
Inpatient Visit
IP [9201]
IP [9201]
6.5e-01
1.1e+00
1.4e+00
1.0e+50
2.9e+00
1.0e+00
5.6e-01
cases:16.62%
controls:9.45%
cases:11.08%
controls:4.12%
cases:2.11%
controls:0.53%
cases:1.32%
controls:0.00%
cases:6.63%
controls:0.37%
cases:10.23%
controls:3.97%
cases:16.94%
controls:10.47%
63
358
316
3432
42
156
337
3634
8
20
371
3770
5
0
374
3790
25
14
352
3757
35
141
307
3409
42
270
206
2310
Pain in limb
M79.6 [45587063]
M79.6 [45587063]
7.3e-01
8.5e-01
1.9e+00
—
1.1e+00
1.3e+00
9.2e-01
cases:16.62%
controls:8.76%
cases:7.39%
controls:3.30%
cases:2.90%
controls:0.45%
—
—
cases:2.12%
controls:0.69%
cases:10.53%
controls:3.18%
cases:22.58%
controls:10.43%
63
332
316
3458
28
125
351
3665
11
17
368
3773
—
8
26
369
3745
36
113
306
3437
56
269
192
2311
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
14749-6 [3013826]
3.5e-01
7.1e-01
1.9e+00
—
1.8e+00
6.6e-01
6.2e-01
cases:25.59%
controls:19.58%
cases:16.89%
controls:9.08%
cases:6.33%
controls:1.00%
—
—
cases:5.84%
controls:1.06%
cases:15.50%
controls:8.68%
cases:28.23%
controls:17.40%
97
742
282
3048
64
344
315
3446
24
38
355
3752
—
22
40
355
3731
53
308
289
3242
70
449
178
2131
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
34487-9 [3044938]
4.5e-01
1.0e+00
-1.0e+50
—
2.3e+00
1.3e+00
8.7e-01
cases:5.54%
controls:3.59%
cases:4.75%
controls:1.72%
cases:0.00%
controls:0.21%
—
—
cases:1.86%
controls:0.19%
cases:5.56%
controls:1.61%
cases:9.68%
controls:4.30%
21
136
358
3654
18
65
361
3725
0
8
379
3782
—
7
7
370
3764
19
57
323
3493
24
111
224
2469
Laboratory Visit
OMOP4822461 [32036]
OMOP4822461 [32036]
1.5e-02
2.5e-01
7.8e-01
3.6e+00
1.1e+00
1.6e-01
2.2e-02
cases:60.69%
controls:60.32%
cases:57.78%
controls:51.66%
cases:28.76%
controls:15.59%
cases:24.27%
controls:0.87%
cases:35.54%
controls:15.86%
cases:56.14%
controls:52.11%
cases:61.29%
controls:60.78%
230
2286
149
1504
219
1958
160
1832
109
591
270
3199
92
33
287
3757
134
598
243
3173
192
1850
150
1700
152
1568
96
1012
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
34531-4 [3044640]
5.4e-01
1.0e+00
1.5e+00
—
3.1e+00
7.3e-01
7.0e-01
cases:15.83%
controls:9.89%
cases:9.50%
controls:3.61%
cases:1.85%
controls:0.42%
—
—
cases:6.90%
controls:0.32%
cases:6.14%
controls:3.07%
cases:13.31%
controls:7.05%
60
375
319
3415
36
137
343
3653
7
16
372
3774
—
26
12
351
3759
21
109
321
3441
33
182
215
2398
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
19072-8 [3016431]
4.6e-01
9.2e-01
1.1e+00
—
1.6e+00
7.6e-01
5.6e-01
cases:22.43%
controls:15.46%
cases:18.21%
controls:8.15%
cases:3.69%
controls:1.24%
—
—
cases:5.84%
controls:1.25%
cases:14.91%
controls:7.61%
cases:24.60%
controls:15.66%
85
586
294
3204
69
309
310
3481
14
47
365
3743
—
22
47
355
3724
51
270
291
3280
61
404
187
2176
Bacteria [Presence] in Urine
87829-8 [36304419]
87829-8 [36304419]
8.1e-01
1.0e+00
1.0e+00
—
1.4e+00
1.1e+00
1.0e+00
cases:16.09%
controls:7.84%
cases:9.50%
controls:3.67%
cases:1.58%
controls:0.58%
—
—
cases:2.92%
controls:0.72%
cases:9.36%
controls:3.27%
cases:19.76%
controls:8.26%
61
297
318
3493
36
139
343
3651
6
22
373
3768
—
11
27
366
3744
32
116
310
3434
49
213
199
2367
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
51483-6 [3030467]
7.5e-01
1.1e+00
9.7e-01
—
1.4e+00
1.1e+00
9.7e-01
cases:15.57%
controls:8.02%
cases:9.76%
controls:3.64%
cases:1.58%
controls:0.61%
—
—
cases:2.92%
controls:0.72%
cases:9.65%
controls:3.58%
cases:20.16%
controls:8.72%
59
304
320
3486
37
138
342
3652
6
23
373
3767
—
11
27
366
3744
33
127
309
3423
50
225
198
2355
Physiotherapist
Z3226 [2001311560]
Z3226 [2001311560]
1.1e+00
—
—
—
—
2.4e+00
1.7e+00
cases:4.22%
controls:1.42%
—
—
—
—
—
—
—
—
cases:2.05%
controls:0.20%
cases:4.44%
controls:0.81%
16
54
363
3736
—
—
—
—
7
7
335
3543
11
21
237
2559
Methemoglobin/Hemoglobin.total in Arterial blood
2615-3 [3006217]
2615-3 [3006217]
7.6e-01
1.9e+00
—
—
—
2.2e+00
1.1e+00
cases:2.90%
controls:1.37%
cases:3.43%
controls:0.53%
—
—
—
—
—
—
cases:3.22%
controls:0.37%
cases:5.24%
controls:1.82%
11
52
368
3738
13
20
366
3770
—
—
—
11
13
331
3537
13
47
235
2533
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
1751-7 [3024561]
5.6e-01
7.9e-01
1.3e+00
—
1.7e+00
8.4e-01
5.3e-01
cases:22.16%
controls:13.93%
cases:13.72%
controls:6.73%
cases:2.90%
controls:0.79%
—
—
cases:5.84%
controls:1.17%
cases:13.74%
controls:6.42%
cases:20.97%
controls:13.53%
84
528
295
3262
52
255
327
3535
11
30
368
3760
—
22
44
355
3727
47
228
295
3322
52
349
196
2231
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
N02BE01 [21604344]
3.4e-01
3.6e-01
7.9e-01
2.1e+00
1.1e+00
5.4e-01
5.9e-01
cases:48.28%
controls:39.87%
cases:29.02%
controls:22.16%
cases:9.23%
controls:4.41%
cases:2.11%
controls:0.26%
cases:13.26%
controls:4.77%
cases:32.16%
controls:21.72%
cases:53.23%
controls:38.76%
183
1511
196
2279
110
840
269
2950
35
167
344
3623
8
10
371
3780
50
180
327
3591
110
771
232
2779
132
1000
116
1580
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
2157-6 [3007220]
5.7e-01
6.0e-01
2.0e+00
1.0e+50
2.4e+00
7.6e-01
3.5e-01
cases:13.46%
controls:8.10%
cases:5.54%
controls:3.11%
cases:1.58%
controls:0.21%
cases:2.90%
controls:0.00%
cases:2.65%
controls:0.24%
cases:5.85%
controls:2.82%
cases:10.48%
controls:7.64%
51
307
328
3483
21
118
358
3672
6
8
373
3782
11
0
368
3790
10
9
367
3762
20
100
322
3450
26
197
222
2383
Mixed personality disorders
F61.0 [2000502024]
F61.0 [2000502024]
2.5e+00
2.5e+00
—
—
—
—
—
cases:1.58%
controls:0.13%
cases:1.58%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
6
5
373
3785
6
5
373
3785
—
—
—
—
—
clindamycin; oral, parenteral
J01FF01 [21602985]
J01FF01 [21602985]
9.5e-01
1.3e+00
—
—
—
1.5e+00
1.1e+00
cases:8.44%
controls:3.46%
cases:3.17%
controls:0.90%
—
—
—
—
—
—
cases:5.56%
controls:1.24%
cases:8.47%
controls:2.87%
32
131
347
3659
12
34
367
3756
—
—
—
19
44
323
3506
21
74
227
2506
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
N02AX02 [21604298]
1.0e+00
1.0e+00
1.1e+00
—
1.9e+00
1.0e+00
7.0e-01
cases:16.62%
controls:6.86%
cases:6.86%
controls:2.59%
cases:1.85%
controls:0.63%
—
—
cases:3.45%
controls:0.56%
cases:6.43%
controls:2.37%
cases:12.10%
controls:6.40%
63
260
316
3530
26
98
353
3692
7
24
372
3766
—
13
21
364
3750
22
84
320
3466
30
165
218
2415
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
77397-8 [46236098]
5.4e-01
9.6e-01
1.7e+00
—
3.0e+00
8.2e-01
8.0e-01
cases:11.87%
controls:7.26%
cases:7.12%
controls:2.85%
cases:1.58%
controls:0.29%
—
—
cases:5.57%
controls:0.29%
cases:5.26%
controls:2.39%
cases:10.48%
controls:5.00%
45
275
334
3515
27
108
352
3682
6
11
373
3779
—
21
11
356
3760
18
85
324
3465
26
129
222
2451
Physical Medicine And Rehabilitation
25 [38004468]
25 [38004468]
5.3e-01
9.0e-01
1.6e+00
—
1.9e+00
9.4e-01
9.9e-01
cases:10.82%
controls:6.68%
cases:5.01%
controls:2.11%
cases:1.58%
controls:0.32%
—
—
cases:3.18%
controls:0.48%
cases:6.43%
controls:2.62%
cases:14.11%
controls:5.78%
41
253
338
3537
19
80
360
3710
6
12
373
3778
—
12
18
365
3753
22
93
320
3457
35
149
213
2431
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
30391-7 [3002582]
7.5e-01
8.6e-01
9.3e-01
1.0e+50
1.3e+00
9.1e-01
8.6e-01
cases:17.94%
controls:9.37%
cases:10.29%
controls:4.62%
cases:1.85%
controls:0.74%
cases:1.32%
controls:0.00%
cases:3.18%
controls:0.85%
cases:9.94%
controls:4.25%
cases:21.37%
controls:10.31%
68
355
311
3435
39
175
340
3615
7
28
372
3762
5
0
374
3790
12
32
365
3739
34
151
308
3399
53
266
195
2314
Foot/toe symptom/complaint
L17 [2002000641]
L17 [2002000641]
1.0e+00
1.1e+00
2.5e+00
—
—
2.9e-01
5.2e-01
cases:13.72%
controls:5.30%
cases:5.80%
controls:1.95%
cases:2.64%
controls:0.21%
—
—
—
—
cases:3.51%
controls:2.65%
cases:9.68%
controls:5.97%
52
201
327
3589
22
74
357
3716
10
8
369
3782
—
—
12
94
330
3456
24
154
224
2426
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
2021-4 [3021447]
8.8e-01
1.7e+00
—
—
2.2e+00
8.6e-01
8.5e-01
cases:6.60%
controls:2.85%
cases:5.28%
controls:1.03%
—
—
—
—
cases:1.59%
controls:0.19%
cases:3.22%
controls:1.38%
cases:7.66%
controls:3.41%
25
108
354
3682
20
39
359
3751
—
—
6
7
371
3764
11
49
331
3501
19
88
229
2492
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
10839-9 [3021337]
8.1e-01
9.5e-01
1.4e+00
—
2.0e+00
5.1e-01
9.6e-01
cases:11.61%
controls:5.54%
cases:5.80%
controls:2.32%
cases:1.32%
controls:0.34%
—
—
cases:1.86%
controls:0.27%
cases:3.80%
controls:2.31%
cases:12.50%
controls:5.19%
44
210
335
3580
22
88
357
3702
5
13
374
3777
—
7
10
370
3761
13
82
329
3468
31
134
217
2446
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
14979-9 [3018677]
1.0e+00
1.1e+00
—
1.0e+50
—
1.4e+00
1.1e+00
cases:10.03%
controls:3.77%
cases:3.96%
controls:1.35%
—
—
cases:1.58%
controls:0.00%
—
—
cases:4.68%
controls:1.21%
cases:9.68%
controls:3.33%
38
143
341
3647
15
51
364
3739
—
6
0
373
3790
—
16
43
326
3507
24
86
224
2494
Oxygen capacity [Volume Fraction] in Arterial blood
59275-8 [40762366]
59275-8 [40762366]
9.1e-01
1.6e+00
—
—
—
1.7e+00
1.4e+00
cases:2.90%
controls:1.19%
cases:2.64%
controls:0.55%
—
—
—
—
—
—
cases:2.34%
controls:0.45%
cases:5.24%
controls:1.36%
11
45
368
3745
10
21
369
3769
—
—
—
8
16
334
3534
13
35
235
2545
Outpatient Hospital
22 [8756]
22 [8756]
3.5e-01
6.7e-01
1.5e+00
1.0e+50
2.1e+00
1.1e+00
7.6e-01
cases:27.70%
controls:21.32%
cases:8.44%
controls:4.49%
cases:1.85%
controls:0.42%
cases:5.28%
controls:0.00%
cases:3.71%
controls:0.48%
cases:8.77%
controls:3.13%
cases:22.58%
controls:12.05%
105
808
274
2982
32
170
347
3620
7
16
372
3774
20
0
359
3790
14
18
363
3753
30
111
312
3439
56
311
192
2269
pH of Serum or Plasma
2753-2 [3018418]
2753-2 [3018418]
5.6e-01
1.0e+00
9.3e-01
—
1.6e+00
8.1e-01
6.5e-01
cases:13.98%
controls:8.50%
cases:10.82%
controls:4.20%
cases:2.11%
controls:0.84%
—
—
cases:3.18%
controls:0.69%
cases:8.48%
controls:3.94%
cases:15.73%
controls:8.84%
53
322
326
3468
41
159
338
3631
8
32
371
3758
—
12
26
365
3745
29
140
313
3410
39
228
209
2352
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
51486-9 [3029879]
1.0e+00
1.2e+00
1.1e+00
1.0e+50
1.4e+00
1.3e+00
9.8e-01
cases:11.35%
controls:4.30%
cases:8.18%
controls:2.59%
cases:1.32%
controls:0.45%
cases:1.32%
controls:0.00%
cases:2.12%
controls:0.56%
cases:7.02%
controls:1.94%
cases:13.71%
controls:5.62%
43
163
336
3627
31
98
348
3692
5
17
374
3773
5
0
374
3790
8
21
369
3750
24
69
318
3481
34
145
214
2435
flucloxacillin; oral, parenteral
J01CF05 [21602857]
J01CF05 [21602857]
1.4e+00
1.6e+00
—
—
—
1.5e+00
1.5e+00
cases:2.64%
controls:0.63%
cases:2.11%
controls:0.42%
—
—
—
—
—
—
cases:2.34%
controls:0.54%
cases:4.84%
controls:1.12%
10
24
369
3766
8
16
371
3774
—
—
—
8
19
334
3531
12
29
236
2551
Pelvis X-ray examination
NE1AA [2001307792]
NE1AA [2001307792]
9.6e-01
2.1e+00
—
—
—
2.5e+00
1.3e+00
cases:2.37%
controls:0.92%
cases:1.85%
controls:0.24%
—
—
—
—
—
—
cases:2.34%
controls:0.20%
cases:2.82%
controls:0.81%
9
35
370
3755
7
9
372
3781
—
—
—
8
7
334
3543
7
21
241
2559
CBC panel - Blood by Automated count
58410-2 [40761511]
58410-2 [40761511]
1.5e-01
3.2e-01
6.1e-01
3.4e+00
1.0e+00
-1.2e-01
-5.7e-02
cases:50.40%
controls:46.60%
cases:33.51%
controls:26.73%
cases:7.92%
controls:4.46%
cases:7.39%
controls:0.26%
cases:13.53%
controls:5.20%
cases:24.56%
controls:26.79%
cases:41.13%
controls:42.52%
191
1766
188
2024
127
1013
252
2777
30
169
349
3621
28
10
351
3780
51
196
326
3575
84
951
258
2599
102
1097
146
1483
Leukocytes [#/volume] in Urine
30405-5 [3018095]
30405-5 [3018095]
6.5e-01
8.0e-01
7.3e-01
—
1.5e+00
7.9e-01
7.4e-01
cases:18.47%
controls:10.58%
cases:12.14%
controls:5.83%
cases:1.85%
controls:0.90%
—
—
cases:4.24%
controls:1.01%
cases:12.28%
controls:5.97%
cases:22.98%
controls:12.48%
70
401
309
3389
46
221
333
3569
7
34
372
3756
—
16
38
361
3733
42
212
300
3338
57
322
191
2258
Supplier / Service Provider
OMOP5117446 [33004]
OMOP5117446 [33004]
-2.7e-01
-1.6e-01
1.2e+00
—
—
2.2e+00
2.3e+00
cases:24.80%
controls:30.18%
cases:7.39%
controls:8.52%
cases:2.11%
controls:0.63%
—
—
—
—
cases:5.56%
controls:0.68%
cases:13.31%
controls:1.59%
94
1144
285
2646
28
323
351
3467
8
24
371
3766
—
—
19
24
323
3526
33
41
215
2539
enoxaparin; parenteral
B01AB05 [21600976]
B01AB05 [21600976]
7.1e-01
1.2e+00
—
—
2.5e+00
1.1e+00
8.2e-01
cases:10.03%
controls:5.17%
cases:4.22%
controls:1.37%
—
—
—
—
cases:1.59%
controls:0.13%
cases:3.22%
controls:1.10%
cases:8.87%
controls:4.11%
38
196
341
3594
16
52
363
3738
—
—
6
5
371
3766
11
39
331
3511
22
106
226
2474
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 [3030306]
51485-1 [3030306]
9.7e-01
1.2e+00
1.1e+00
—
1.2e+00
1.2e+00
9.4e-01
cases:10.55%
controls:4.30%
cases:8.71%
controls:2.72%
cases:1.32%
controls:0.45%
—
—
cases:2.12%
controls:0.66%
cases:7.31%
controls:2.37%
cases:14.92%
controls:6.43%
40
163
339
3627
33
103
346
3687
5
17
374
3773
—
8
25
369
3746
25
84
317
3466
37
166
211
2414
Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
95941-1 [36031861]
95941-1 [36031861]
8.7e-01
1.5e+00
-1.0e+50
—
—
1.6e+00
1.1e+00
cases:2.11%
controls:0.90%
cases:2.64%
controls:0.58%
cases:0.00%
controls:0.13%
—
—
—
—
cases:3.22%
controls:0.65%
cases:5.65%
controls:1.90%
8
34
371
3756
10
22
369
3768
0
5
379
3785
—
—
11
23
331
3527
14
49
234
2531
Left side
ZXA05 [2001311347]
ZXA05 [2001311347]
8.5e-01
1.2e+00
—
1.0e+50
—
2.2e+00
1.3e+00
cases:5.80%
controls:2.56%
cases:2.11%
controls:0.63%
—
—
cases:1.32%
controls:0.00%
—
—
cases:2.63%
controls:0.31%
cases:5.24%
controls:1.55%
22
97
357
3693
8
24
371
3766
—
5
0
374
3790
—
9
11
333
3539
13
40
235
2540
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
50554-5 [3029287]
6.4e-01
8.0e-01
1.1e+00
1.0e+50
1.4e+00
7.5e-01
7.1e-01
cases:19.00%
controls:11.00%
cases:10.29%
controls:4.88%
cases:2.11%
controls:0.69%
cases:1.32%
controls:0.00%
cases:2.92%
controls:0.77%
cases:9.06%
controls:4.48%
cases:20.16%
controls:11.01%
72
417
307
3373
39
185
340
3605
8
26
371
3764
5
0
374
3790
11
29
366
3742
31
159
311
3391
50
284
198
2296
Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1805-1 [3016417]
1805-1 [3016417]
9.6e-01
1.6e+00
—
—
—
1.6e+00
8.7e-01
cases:5.80%
controls:2.30%
cases:4.22%
controls:0.84%
—
—
—
—
—
—
cases:4.39%
controls:0.87%
cases:4.84%
controls:2.09%
22
87
357
3703
16
32
363
3758
—
—
—
15
31
327
3519
12
54
236
2526
oxycodone and naloxone; oral
N02AA55 [21604265]
N02AA55 [21604265]
3.7e-01
1.2e+00
—
—
2.0e+00
1.0e+00
1.1e-01
cases:4.49%
controls:3.14%
cases:4.22%
controls:1.32%
—
—
—
—
cases:2.12%
controls:0.29%
cases:4.09%
controls:1.49%
cases:4.03%
controls:3.64%
17
119
362
3671
16
50
363
3740
—
—
8
11
369
3760
14
53
328
3497
10
94
238
2486
Limited function/disability (L)
L28 [2002000647]
L28 [2002000647]
7.9e-01
1.3e+00
1.5e+00
—
1.7e+00
1.2e+00
9.3e-01
cases:6.33%
controls:2.98%
cases:5.01%
controls:1.45%
cases:1.32%
controls:0.29%
—
—
cases:1.59%
controls:0.29%
cases:5.85%
controls:1.77%
cases:9.27%
controls:3.88%
24
113
355
3677
19
55
360
3735
5
11
374
3779
—
6
11
371
3760
20
63
322
3487
23
100
225
2480
Nephrology
39 [38004479]
39 [38004479]
1.1e+00
1.3e+00
—
—
1.9e+00
1.3e+00
8.3e-01
cases:3.69%
controls:1.32%
cases:3.17%
controls:0.90%
—
—
—
—
cases:1.86%
controls:0.29%
cases:2.92%
controls:0.79%
cases:3.23%
controls:1.43%
14
50
365
3740
12
34
367
3756
—
—
7
11
370
3760
10
28
332
3522
8
37
240
2543
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
22664-7 [3020779]
8.7e-01
9.2e-01
1.6e+00
—
1.9e+00
1.3e+00
6.0e-01
cases:5.54%
controls:2.40%
cases:3.43%
controls:1.40%
cases:1.32%
controls:0.26%
—
—
cases:2.12%
controls:0.32%
cases:3.80%
controls:1.01%
cases:4.44%
controls:2.48%
21
91
358
3699
13
53
366
3737
5
10
374
3780
—
8
12
369
3759
13
36
329
3514
11
64
237
2516
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
1920-8 [3013721]
7.6e-01
8.0e-01
1.4e+00
—
1.6e+00
9.7e-01
5.2e-01
cases:19.00%
controls:9.87%
cases:9.23%
controls:4.35%
cases:1.32%
controls:0.32%
—
—
cases:3.18%
controls:0.66%
cases:9.94%
controls:4.03%
cases:13.31%
controls:8.33%
72
374
307
3416
35
165
344
3625
5
12
374
3778
—
12
25
365
3746
34
143
308
3407
33
215
215
2365
Venous insufficiency (chronic)(peripheral)
I87.2 [45552867]
I87.2 [45552867]
1.4e+00
1.4e+00
—
1.0e+50
1.0e+50
1.5e+00
1.2e+00
cases:4.75%
controls:1.24%
cases:1.85%
controls:0.47%
—
—
cases:1.32%
controls:0.00%
cases:1.33%
controls:0.00%
cases:3.51%
controls:0.85%
cases:6.05%
controls:1.82%
18
47
361
3743
7
18
372
3772
—
5
0
374
3790
5
0
372
3771
12
30
330
3520
15
47
233
2533
Internal Medicine
11 [38004456]
11 [38004456]
6.5e-01
6.1e-01
9.8e-01
—
1.2e+00
1.1e+00
5.5e-01
cases:32.45%
controls:20.00%
cases:12.93%
controls:7.47%
cases:2.90%
controls:1.11%
—
—
cases:3.45%
controls:1.09%
cases:16.67%
controls:6.37%
cases:27.42%
controls:17.91%
123
758
256
3032
49
283
330
3507
11
42
368
3748
—
13
41
364
3730
57
226
285
3324
68
462
180
2118
Ankle X-ray examination without contrast
NH1AA [2001308235]
NH1AA [2001308235]
1.0e+00
—
—
—
—
2.4e+00
1.7e+00
cases:1.85%
controls:0.66%
—
—
—
—
—
—
—
—
cases:2.34%
controls:0.23%
cases:4.03%
controls:0.78%
7
25
372
3765
—
—
—
—
8
8
334
3542
10
20
238
2560
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
1742-6 [3006923]
1.9e-01
4.0e-01
3.8e-01
2.6e+00
1.0e+00
2.6e-01
-1.5e-02
cases:53.30%
controls:48.50%
cases:42.48%
controls:33.01%
cases:8.18%
controls:5.73%
cases:2.11%
controls:0.16%
cases:14.85%
controls:5.97%
cases:39.47%
controls:33.38%
cases:49.60%
controls:49.96%
202
1838
177
1952
161
1251
218
2539
31
217
348
3573
8
6
371
3784
56
225
321
3546
135
1185
207
2365
123
1289
125
1291
Bicarbonate [Moles/volume] standard in Venous blood
19232-8 [3007628]
19232-8 [3007628]
1.1e+00
1.7e+00
—
—
—
7.4e-01
1.2e+00
cases:3.96%
controls:1.35%
cases:3.17%
controls:0.61%
—
—
—
—
—
—
cases:1.75%
controls:0.85%
cases:6.45%
controls:2.02%
15
51
364
3739
12
23
367
3767
—
—
—
6
30
336
3520
16
52
232
2528
acetylsalicylic acid; oral, parenteral, rectal
N02BA01 [21604305]
N02BA01 [21604305]
1.0e+00
1.2e+00
1.7e+00
—
1.1e+00
8.0e-01
4.5e-01
cases:6.07%
controls:2.22%
cases:3.69%
controls:1.19%
cases:2.37%
controls:0.42%
—
—
cases:1.33%
controls:0.45%
cases:3.22%
controls:1.46%
cases:4.03%
controls:2.60%
23
84
356
3706
14
45
365
3745
9
16
370
3774
—
5
17
372
3754
11
52
331
3498
10
67
238
2513
Low back pain
M54.5 [45553207]
M54.5 [45553207]
7.4e-01
1.0e+00
2.2e+00
—
—
2.0e-01
6.1e-01
cases:14.78%
controls:7.65%
cases:7.92%
controls:2.93%
cases:1.58%
controls:0.18%
—
—
—
—
cases:3.80%
controls:3.13%
cases:13.31%
controls:7.71%
56
290
323
3500
30
111
349
3679
6
7
373
3783
—
—
13
111
329
3439
33
199
215
2381
Carboxyhemoglobin/Hemoglobin.total in Arterial blood
2030-5 [3028653]
2030-5 [3028653]
6.7e-01
1.9e+00
—
—
—
2.1e+00
9.7e-01
cases:2.64%
controls:1.37%
cases:3.43%
controls:0.55%
—
—
—
—
—
—
cases:3.22%
controls:0.42%
cases:5.24%
controls:2.05%
10
52
369
3738
13
21
366
3769
—
—
—
11
15
331
3535
13
53
235
2527
Foot and toes X-ray examination
NH3AA [2001308267]
NH3AA [2001308267]
8.0e-01
1.8e+00
—
1.0e+50
—
2.1e+00
1.2e+00
cases:2.37%
controls:1.08%
cases:2.11%
controls:0.37%
—
—
cases:2.11%
controls:0.00%
—
—
cases:2.34%
controls:0.28%
cases:2.42%
controls:0.78%
9
41
370
3749
8
14
371
3776
—
8
0
371
3790
—
8
10
334
3540
6
20
242
2560
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
26511-6 [3018010]
7.1e-01
8.8e-01
7.8e-01
—
1.4e+00
8.1e-01
4.6e-01
cases:27.97%
controls:16.04%
cases:17.94%
controls:8.31%
cases:3.96%
controls:1.85%
—
—
cases:6.90%
controls:1.75%
cases:17.84%
controls:8.79%
cases:23.39%
controls:16.16%
106
608
273
3182
68
315
311
3475
15
70
364
3720
—
26
66
351
3705
61
312
281
3238
58
417
190
2163
Fractional oxyhemoglobin in Arterial blood
2714-4 [3014007]
2714-4 [3014007]
7.6e-01
1.8e+00
—
—
—
2.1e+00
9.5e-01
cases:2.90%
controls:1.37%
cases:3.17%
controls:0.55%
—
—
—
—
—
—
cases:3.22%
controls:0.42%
cases:4.84%
controls:1.94%
11
52
368
3738
12
21
367
3769
—
—
—
11
15
331
3535
12
50
236
2530
Swelling
A08 [2002000149]
A08 [2002000149]
1.3e+00
—
—
—
—
2.2e+00
1.6e+00
cases:2.37%
controls:0.66%
—
—
—
—
—
—
—
—
cases:1.75%
controls:0.20%
cases:4.44%
controls:0.93%
9
25
370
3765
—
—
—
—
6
7
336
3543
11
24
237
2556
Differential panel, method unspecified - Blood
69738-3 [42870588]
69738-3 [42870588]
7.0e-01
8.8e-01
7.8e-01
—
1.3e+00
8.8e-01
5.9e-01
cases:20.58%
controls:11.42%
cases:13.72%
controls:6.20%
cases:3.17%
controls:1.48%
—
—
cases:4.77%
controls:1.33%
cases:13.45%
controls:6.06%
cases:17.74%
controls:10.70%
78
433
301
3357
52
235
327
3555
12
56
367
3734
—
18
50
359
3721
46
215
296
3335
44
276
204
2304
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
26450-7 [3006504]
6.8e-01
8.5e-01
6.8e-01
—
1.3e+00
8.1e-01
4.5e-01
cases:27.44%
controls:16.04%
cases:17.41%
controls:8.28%
cases:3.69%
controls:1.90%
—
—
cases:6.37%
controls:1.80%
cases:17.54%
controls:8.62%
cases:22.58%
controls:15.66%
104
608
275
3182
66
314
313
3476
14
72
365
3718
—
24
68
353
3703
60
306
282
3244
56
404
192
2176
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
26478-8 [3002030]
6.6e-01
8.5e-01
7.6e-01
—
1.3e+00
8.2e-01
4.6e-01
cases:27.44%
controls:16.33%
cases:17.68%
controls:8.42%
cases:3.96%
controls:1.90%
—
—
cases:6.63%
controls:1.86%
cases:18.13%
controls:8.90%
cases:23.39%
controls:16.16%
104
619
275
3171
67
319
312
3471
15
72
364
3718
—
25
70
352
3701
62
316
280
3234
58
417
190
2163
Monocytes/Leukocytes in Blood
26485-3 [3019069]
26485-3 [3019069]
6.7e-01
8.5e-01
7.0e-01
—
1.3e+00
8.2e-01
4.6e-01
cases:27.18%
controls:16.04%
cases:17.41%
controls:8.23%
cases:3.69%
controls:1.87%
—
—
cases:6.37%
controls:1.80%
cases:17.54%
controls:8.59%
cases:22.58%
controls:15.58%
103
608
276
3182
66
312
313
3478
14
71
365
3719
—
24
68
353
3703
60
305
282
3245
56
402
192
2178
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
751-8 [3013650]
4.6e-01
7.8e-01
6.4e-01
—
1.1e+00
7.5e-01
5.3e-01
cases:28.50%
controls:20.03%
cases:20.32%
controls:10.47%
cases:4.75%
controls:2.56%
—
—
cases:7.16%
controls:2.52%
cases:20.76%
controls:10.99%
cases:29.03%
controls:19.42%
108
759
271
3031
77
397
302
3393
18
97
361
3693
—
27
95
350
3676
71
390
271
3160
72
501
176
2079
Basophils/Leukocytes in Blood
30180-4 [3022096]
30180-4 [3022096]
6.7e-01
8.4e-01
7.0e-01
—
1.3e+00
8.2e-01
4.5e-01
cases:27.18%
controls:16.04%
cases:17.41%
controls:8.34%
cases:3.69%
controls:1.87%
—
—
cases:6.10%
controls:1.80%
cases:17.84%
controls:8.70%
cases:22.58%
controls:15.62%
103
608
276
3182
66
316
313
3474
14
71
365
3719
—
23
68
354
3703
61
309
281
3241
56
403
192
2177
Other diagnostic examination of periferal vessel
XPX99 [2001309755]
XPX99 [2001309755]
1.5e+00
—
—
—
—
2.1e+00
1.7e+00
cases:3.43%
controls:0.82%
—
—
—
—
—
—
—
—
cases:2.05%
controls:0.25%
cases:2.42%
controls:0.47%
13
31
366
3759
—
—
—
—
7
9
335
3541
6
12
242
2568
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
1995-0 [3021347]
4.9e-01
9.2e-01
9.6e-01
—
1.4e+00
7.0e-01
5.5e-01
cases:20.84%
controls:13.85%
cases:16.09%
controls:7.07%
cases:2.90%
controls:1.13%
—
—
cases:4.51%
controls:1.11%
cases:12.28%
controls:6.48%
cases:21.37%
controls:13.53%
79
525
300
3265
61
268
318
3522
11
43
368
3747
—
17
42
360
3729
42
230
300
3320
53
349
195
2231
Base excess in Venous blood by calculation
1927-3 [3002032]
1927-3 [3002032]
8.8e-01
1.7e+00
—
—
2.0e+00
8.1e-01
9.6e-01
cases:6.60%
controls:2.85%
cases:5.01%
controls:0.98%
—
—
—
—
cases:1.33%
controls:0.19%
cases:2.92%
controls:1.32%
cases:8.47%
controls:3.41%
25
108
354
3682
19
37
360
3753
—
—
5
7
372
3764
10
47
332
3503
21
88
227
2492
Sedation and analgesia
WX002 [2001310758]
WX002 [2001310758]
7.6e-01
—
—
—
—
1.9e+00
1.6e+00
cases:6.07%
controls:2.93%
—
—
—
—
—
—
—
—
cases:2.34%
controls:0.37%
cases:6.05%
controls:1.24%
23
111
356
3679
—
—
—
—
8
13
334
3537
15
32
233
2548
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
14631-6 [3006140]
5.4e-01
7.4e-01
6.8e-01
—
1.6e+00
6.0e-01
5.0e-01
cases:24.54%
controls:15.96%
cases:15.30%
controls:7.94%
cases:2.11%
controls:1.08%
—
—
cases:6.63%
controls:1.38%
cases:12.87%
controls:7.46%
cases:23.39%
controls:15.62%
93
605
286
3185
58
301
321
3489
8
41
371
3749
—
25
52
352
3719
44
265
298
3285
58
403
190
2177
Monocytes [#/volume] in Blood
26484-6 [3001604]
26484-6 [3001604]
5.9e-01
8.1e-01
6.4e-01
—
1.3e+00
7.8e-01
3.9e-01
cases:26.65%
controls:16.81%
cases:17.94%
controls:8.87%
cases:3.69%
controls:1.98%
—
—
cases:6.37%
controls:1.78%
cases:18.42%
controls:9.38%
cases:24.19%
controls:17.79%
101
637
278
3153
68
336
311
3454
14
75
365
3715
—
24
67
353
3704
63
333
279
3217
60
459
188
2121
Unspecified fall
W19 [45756257]
W19 [45756257]
1.0e+00
—
—
1.0e+50
—
2.0e+00
1.5e+00
cases:2.90%
controls:1.08%
—
—
—
—
cases:3.17%
controls:0.00%
—
—
cases:2.92%
controls:0.39%
cases:5.24%
controls:1.28%
11
41
368
3749
—
—
12
0
367
3790
—
10
14
332
3536
13
33
235
2547
Basophils [#/volume] in Blood
26444-0 [3006315]
26444-0 [3006315]
5.9e-01
8.0e-01
6.4e-01
—
1.3e+00
7.8e-01
3.8e-01
cases:26.65%
controls:16.81%
cases:17.94%
controls:8.94%
cases:3.69%
controls:1.98%
—
—
cases:6.37%
controls:1.80%
cases:18.42%
controls:9.41%
cases:24.19%
controls:17.87%
101
637
278
3153
68
339
311
3451
14
75
365
3715
—
24
68
353
3703
63
334
279
3216
60
461
188
2119
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
26474-7 [3019198]
5.7e-01
8.0e-01
7.0e-01
—
1.3e+00
7.8e-01
4.0e-01
cases:26.91%
controls:17.23%
cases:18.21%
controls:9.08%
cases:3.96%
controls:2.01%
—
—
cases:6.63%
controls:1.86%
cases:18.71%
controls:9.58%
cases:25.00%
controls:18.22%
102
653
277
3137
69
344
310
3446
15
76
364
3714
—
25
70
352
3701
64
340
278
3210
62
470
186
2110
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]
29760-6 [3005772]
9.3e-01
1.2e+00
—
—
—
1.3e+00
3.3e-01
cases:7.12%
controls:2.93%
cases:3.69%
controls:1.19%
—
—
—
—
—
—
cases:3.80%
controls:1.01%
cases:3.63%
controls:2.64%
27
111
352
3679
14
45
365
3745
—
—
—
13
36
329
3514
9
68
239
2512
buprenorphine; parenteral, sublingual, transdermal
N02AE01 [21604287]
N02AE01 [21604287]
1.3e+00
1.2e+00
8.7e-01
—
—
9.5e-01
9.8e-01
cases:7.12%
controls:2.14%
cases:5.28%
controls:1.66%
cases:1.32%
controls:0.55%
—
—
—
—
cases:4.39%
controls:1.75%
cases:8.06%
controls:3.18%
27
81
352
3709
20
63
359
3727
5
21
374
3769
—
—
15
62
327
3488
20
82
228
2498
Thrombin time
3243-3 [3036489]
3243-3 [3036489]
1.2e+00
—
—
—
—
2.2e+00
1.5e+00
cases:3.43%
controls:1.06%
—
—
—
—
—
—
—
—
cases:2.05%
controls:0.23%
cases:2.82%
controls:0.66%
13
40
366
3750
—
—
—
—
7
8
335
3542
7
17
241
2563
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
14879-1 [3003458]
8.2e-01
7.8e-01
—
—
1.6e+00
9.7e-01
5.6e-01
cases:8.18%
controls:3.77%
cases:4.75%
controls:2.24%
—
—
—
—
cases:2.39%
controls:0.48%
cases:4.97%
controls:1.94%
cases:6.45%
controls:3.80%
31
143
348
3647
18
85
361
3705
—
—
9
18
368
3753
17
69
325
3481
16
98
232
2482
Eosinophils [#/volume] in Blood
26449-9 [3013115]
26449-9 [3013115]
5.9e-01
7.7e-01
6.4e-01
—
1.3e+00
7.7e-01
4.0e-01
cases:27.44%
controls:17.28%
cases:17.94%
controls:9.16%
cases:3.69%
controls:1.98%
—
—
cases:6.37%
controls:1.88%
cases:18.71%
controls:9.63%
cases:25.00%
controls:18.22%
104
655
275
3135
68
347
311
3443
14
75
365
3715
—
24
71
353
3700
64
342
278
3208
62
470
186
2110
Thorax X-ray examination
GD1AA [2001303617]
GD1AA [2001303617]
5.1e-01
4.9e-01
—
—
2.2e+00
7.0e-01
6.6e-01
cases:15.83%
controls:10.18%
cases:6.07%
controls:3.80%
—
—
—
—
cases:2.39%
controls:0.27%
cases:5.85%
controls:2.99%
cases:15.73%
controls:8.76%
60
386
319
3404
23
144
356
3646
—
—
9
10
368
3761
20
106
322
3444
39
226
209
2354
Pharmacy visit
OMOP4822462 [581458]
OMOP4822462 [581458]
4.8e-01
5.0e-01
5.9e-01
2.0e+00
8.0e-01
6.2e-01
7.2e-01
cases:96.57%
controls:94.56%
cases:90.50%
controls:85.22%
cases:63.32%
controls:48.79%
cases:16.09%
controls:2.59%
cases:67.37%
controls:48.18%
cases:91.23%
controls:84.82%
cases:97.58%
controls:95.16%
366
3584
13
206
343
3230
36
560
240
1849
139
1941
61
98
318
3692
254
1817
123
1954
312
3011
30
539
242
2455
6
125
Occupational therapy
R4120 [2001310234]
R4120 [2001310234]
1.6e+00
—
—
—
—
—
1.7e+00
cases:3.96%
controls:0.84%
—
—
—
—
—
—
—
—
—
—
cases:3.23%
controls:0.58%
15
32
364
3758
—
—
—
—
—
8
15
240
2565
Atrial fibrillation and flutter
I48 [45596206]
I48 [45596206]
6.3e-01
9.9e-01
1.4e+00
—
1.7e+00
6.2e-01
5.9e-01
cases:11.87%
controls:6.68%
cases:7.65%
controls:2.98%
cases:2.37%
controls:0.61%
—
—
cases:2.92%
controls:0.56%
cases:5.56%
controls:3.07%
cases:9.27%
controls:5.39%
45
253
334
3537
29
113
350
3677
9
23
370
3767
—
11
21
366
3750
19
109
323
3441
23
139
225
2441
Limited function/disability NOS
A28 [2002000162]
A28 [2002000162]
7.3e-01
1.2e+00
9.0e-01
—
1.2e+00
1.1e+00
1.0e+00
cases:6.33%
controls:3.17%
cases:6.33%
controls:2.06%
cases:2.11%
controls:0.87%
—
—
cases:2.92%
controls:0.88%
cases:5.85%
controls:2.00%
cases:10.89%
controls:4.30%
24
120
355
3670
24
78
355
3712
8
33
371
3757
—
11
33
366
3738
20
71
322
3479
27
111
221
2469
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
51480-2 [3031040]
4.1e-01
6.1e-01
8.8e-01
—
1.1e+00
5.3e-01
6.2e-01
cases:32.45%
controls:24.17%
cases:17.68%
controls:10.45%
cases:4.22%
controls:1.79%
—
—
cases:4.77%
controls:1.64%
cases:16.67%
controls:10.54%
cases:32.26%
controls:20.39%
123
916
256
2874
67
396
312
3394
16
68
363
3722
—
18
62
359
3709
57
374
285
3176
80
526
168
2054
Normoblasts [#/volume] in Blood
715-3 [3021589]
715-3 [3021589]
6.7e-01
6.5e-01
6.2e-01
—
1.2e+00
6.7e-01
2.4e-01
cases:26.39%
controls:15.44%
cases:19.53%
controls:11.24%
cases:4.49%
controls:2.45%
—
—
cases:7.69%
controls:2.52%
cases:20.47%
controls:11.63%
cases:20.97%
controls:17.25%
100
585
279
3205
74
426
305
3364
17
93
362
3697
—
29
95
348
3676
70
413
272
3137
52
445
196
2135
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
6768-6 [3035995]
4.8e-01
6.1e-01
6.6e-01
—
1.4e+00
6.1e-01
3.1e-01
cases:38.79%
controls:28.21%
cases:26.39%
controls:16.28%
cases:4.75%
controls:2.51%
—
—
cases:10.08%
controls:2.73%
cases:25.15%
controls:15.46%
cases:33.87%
controls:27.40%
147
1069
232
2721
100
617
279
3173
18
95
361
3695
—
38
103
339
3668
86
549
256
3001
84
707
164
1873
prednisolone; oral, parenteral
H02AB06 [21602734]
H02AB06 [21602734]
7.6e-01
8.5e-01
1.0e+00
—
9.3e-01
7.0e-01
7.3e-01
cases:22.43%
controls:11.90%
cases:11.08%
controls:5.04%
cases:3.17%
controls:1.13%
—
—
cases:2.12%
controls:0.85%
cases:9.06%
controls:4.70%
cases:19.76%
controls:10.58%
85
451
294
3339
42
191
337
3599
12
43
367
3747
—
8
32
369
3739
31
167
311
3383
49
273
199
2307
oxycodone; oral, parenteral
N02AA05 [21604260]
N02AA05 [21604260]
7.3e-01
8.2e-01
1.2e+00
—
1.6e+00
1.4e+00
3.9e-01
cases:3.96%
controls:1.95%
cases:3.17%
controls:1.42%
cases:1.85%
controls:0.58%
—
—
cases:3.18%
controls:0.64%
cases:5.26%
controls:1.38%
cases:4.84%
controls:3.33%
15
74
364
3716
12
54
367
3736
7
22
372
3768
—
12
24
365
3747
18
49
324
3501
12
86
236
2494
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
1963-8 [3016293]
6.7e-01
1.5e+00
—
—
—
7.4e-01
1.5e+00
cases:2.90%
controls:1.50%
cases:3.69%
controls:0.84%
—
—
—
—
—
—
cases:1.46%
controls:0.70%
cases:7.66%
controls:1.90%
11
57
368
3733
14
32
365
3758
—
—
—
5
25
337
3525
19
49
229
2531
Erysipelas
A46 [45561706]
A46 [45561706]
1.2e+00
1.7e+00
—
1.0e+50
—
1.2e+00
9.5e-01
cases:6.60%
controls:2.03%
cases:5.01%
controls:0.95%
—
—
cases:2.11%
controls:0.00%
—
—
cases:2.63%
controls:0.79%
cases:6.45%
controls:2.60%
25
77
354
3713
19
36
360
3754
—
8
0
371
3790
—
9
28
333
3522
16
67
232
2513
Psychiatry
26 [38004469]
26 [38004469]
7.4e-01
6.3e-01
1.0e+00
—
1.2e+00
7.8e-01
9.6e-01
cases:11.08%
controls:5.62%
cases:5.28%
controls:2.88%
cases:3.43%
controls:1.27%
—
—
cases:3.45%
controls:1.03%
cases:5.85%
controls:2.76%
cases:12.10%
controls:5.00%
42
213
337
3577
20
109
359
3681
13
48
366
3742
—
13
39
364
3732
20
98
322
3452
30
129
218
2451
macrogol; oral
A06AD15 [21600575]
A06AD15 [21600575]
1.3e+00
1.6e+00
-1.0e+50
—
—
1.1e+00
3.8e-01
cases:4.75%
controls:1.37%
cases:2.64%
controls:0.53%
cases:0.00%
controls:0.21%
—
—
—
—
cases:2.63%
controls:0.90%
cases:4.03%
controls:2.79%
18
52
361
3738
10
20
369
3770
0
8
379
3782
—
—
9
32
333
3518
10
72
238
2508
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
207NI0002X [38003841]
5.9e-01
6.1e-01
1.5e+00
—
9.9e-01
7.9e-01
5.0e-01
cases:13.98%
controls:8.28%
cases:6.07%
controls:3.40%
cases:2.37%
controls:0.53%
—
—
cases:2.12%
controls:0.80%
cases:7.02%
controls:3.32%
cases:11.69%
controls:7.44%
53
314
326
3476
23
129
356
3661
9
20
370
3770
—
8
30
369
3741
24
118
318
3432
29
192
219
2388
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
2524-7 [3014111]
8.6e-01
1.5e+00
—
—
—
1.1e+00
1.4e+00
cases:5.01%
controls:2.19%
cases:4.22%
controls:0.98%
—
—
—
—
—
—
cases:3.51%
controls:1.15%
cases:9.68%
controls:2.67%
19
83
360
3707
16
37
363
3753
—
—
—
12
41
330
3509
24
69
224
2511
gabapentin; oral
N02BF01 [955005]
N02BF01 [955005]
7.8e-01
1.0e+00
9.3e-01
—
1.4e+00
1.0e+00
7.5e-01
cases:7.12%
controls:3.40%
cases:5.54%
controls:2.06%
cases:1.58%
controls:0.63%
—
—
cases:2.39%
controls:0.61%
cases:5.56%
controls:2.11%
cases:8.47%
controls:4.19%
27
129
352
3661
21
78
358
3712
6
24
373
3766
—
9
23
368
3748
19
75
323
3475
21
108
227
2472
Essential (primary) hypertension
I10 [45591453]
I10 [45591453]
3.1e-01
5.0e-01
1.0e+00
—
1.3e+00
4.3e-01
2.4e-01
cases:25.33%
controls:19.97%
cases:16.62%
controls:10.77%
cases:4.75%
controls:1.74%
—
—
cases:6.90%
controls:2.04%
cases:15.50%
controls:10.65%
cases:27.42%
controls:22.87%
96
757
283
3033
63
408
316
3382
18
66
361
3724
—
26
77
351
3694
53
378
289
3172
68
590
180
1990
Exposure to other specified factors
X58 [45756411]
X58 [45756411]
9.0e-01
5.9e-01
2.3e+00
1.0e+50
—
1.6e+00
1.2e+00
cases:4.49%
controls:1.87%
cases:1.32%
controls:0.74%
cases:1.32%
controls:0.13%
cases:8.44%
controls:0.00%
—
—
cases:3.80%
controls:0.79%
cases:5.65%
controls:1.78%
17
71
362
3719
5
28
374
3762
5
5
374
3785
32
0
347
3790
—
13
28
329
3522
14
46
234
2534
Atrial fibrillation/flutter
K78 [2002000605]
K78 [2002000605]
1.1e+00
1.7e+00
—
—
—
1.0e+00
1.2e+00
cases:4.22%
controls:1.48%
cases:2.37%
controls:0.45%
—
—
—
—
—
—
cases:1.46%
controls:0.54%
cases:3.63%
controls:1.12%
16
56
363
3734
9
17
370
3773
—
—
—
5
19
337
3531
9
29
239
2551
warfarin; oral, parenteral
B01AA03 [21600965]
B01AA03 [21600965]
8.8e-01
8.2e-01
1.0e+00
—
1.1e+00
7.1e-01
9.7e-01
cases:10.03%
controls:4.41%
cases:6.60%
controls:3.01%
cases:1.32%
controls:0.47%
—
—
cases:1.86%
controls:0.61%
cases:5.56%
controls:2.82%
cases:7.66%
controls:3.06%
38
167
341
3623
25
114
354
3676
5
18
374
3772
—
7
23
370
3748
19
100
323
3450
19
79
229
2501
Protein [Presence] in Urine by Test strip
20454-5 [3014051]
20454-5 [3014051]
5.6e-01
7.7e-01
—
—
1.9e+00
5.1e-01
3.6e-01
cases:12.40%
controls:7.49%
cases:8.18%
controls:3.96%
—
—
—
—
cases:3.71%
controls:0.58%
cases:7.31%
controls:4.51%
cases:14.52%
controls:10.62%
47
284
332
3506
31
150
348
3640
—
—
14
22
363
3749
25
160
317
3390
36
274
212
2306
Asthma, unspecified
J45.9 [45562456]
J45.9 [45562456]
8.5e-01
8.4e-01
—
1.0e+50
1.8e+00
6.8e-01
5.7e-01
cases:8.71%
controls:3.91%
cases:4.49%
controls:1.98%
—
—
cases:2.37%
controls:0.00%
cases:1.86%
controls:0.32%
cases:3.51%
controls:1.80%
cases:7.66%
controls:4.50%
33
148
346
3642
17
75
362
3715
—
9
0
370
3790
7
12
370
3759
12
64
330
3486
19
116
229
2464
Scheduled procedure
ZXD10 [2001311387]
ZXD10 [2001311387]
5.5e-01
8.1e-01
—
—
—
1.6e+00
1.0e+00
cases:8.97%
controls:5.36%
cases:2.64%
controls:1.19%
—
—
—
—
—
—
cases:3.22%
controls:0.68%
cases:6.85%
controls:2.56%
34
203
345
3587
10
45
369
3745
—
—
—
11
24
331
3526
17
66
231
2514
ECG with 12 standard connections
XF400 [2001303368]
XF400 [2001303368]
9.9e-01
1.4e+00
—
—
—
1.7e+00
1.6e+00
cases:4.75%
controls:1.82%
cases:2.11%
controls:0.55%
—
—
—
—
—
—
cases:1.75%
controls:0.34%
cases:4.84%
controls:1.01%
18
69
361
3721
8
21
371
3769
—
—
—
6
12
336
3538
12
26
236
2554
denosumab; parenteral
M05BX04 [21604169]
M05BX04 [21604169]
1.3e+00
1.3e+00
1.8e+00
—
—
1.0e+00
—
cases:2.90%
controls:0.82%
cases:3.43%
controls:0.95%
cases:1.58%
controls:0.26%
—
—
—
—
cases:2.63%
controls:0.96%
—
—
11
31
368
3759
13
36
366
3754
6
10
373
3780
—
—
9
34
333
3516
—
INR in Blood by Coagulation assay
34714-6 [3032080]
34714-6 [3032080]
5.4e-01
4.8e-01
6.8e-01
—
1.3e+00
4.2e-01
7.2e-01
cases:23.48%
controls:15.17%
cases:11.61%
controls:7.52%
cases:3.43%
controls:1.77%
—
—
cases:6.63%
controls:1.86%
cases:10.23%
controls:6.99%
cases:24.60%
controls:13.76%
89
575
290
3215
44
285
335
3505
13
67
366
3723
—
25
70
352
3701
35
248
307
3302
61
355
187
2225
Lower leg X-ray examination
NG4AA [2001308083]
NG4AA [2001308083]
—
—
—
1.0e+50
—
—
2.5e+00
—
—
—
—
—
—
cases:1.85%
controls:0.00%
—
—
—
—
cases:2.42%
controls:0.19%
—
—
—
7
0
372
3790
—
—
6
5
242
2575
Supine thorax X-ray examination
GD1QA [2001303648]
GD1QA [2001303648]
8.2e-01
1.4e+00
—
—
—
6.7e-01
1.1e+00
cases:4.49%
controls:2.03%
cases:3.17%
controls:0.82%
—
—
—
—
—
—
cases:2.34%
controls:1.21%
cases:9.27%
controls:3.18%
17
77
362
3713
12
31
367
3759
—
—
—
8
43
334
3507
23
82
225
2498
Osmolality of Urine
2695-5 [3026782]
2695-5 [3026782]
3.7e-01
-4.3e-01
—
—
2.5e+00
4.5e-01
6.2e-01
cases:8.71%
controls:6.17%
cases:1.32%
controls:2.01%
—
—
—
—
cases:1.59%
controls:0.13%
cases:2.92%
controls:1.89%
cases:7.26%
controls:4.03%
33
234
346
3556
5
76
374
3714
—
—
6
5
371
3766
10
67
332
3483
18
104
230
2476
Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
9838-4 [3003265]
9838-4 [3003265]
2.5e+00
-1.0e+50
—
—
—
—
—
cases:1.58%
controls:0.13%
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
6
5
373
3785
0
5
379
3785
—
—
—
—
—
Lactate [Moles/volume] in Venous blood
2519-7 [3008037]
2519-7 [3008037]
1.1e+00
2.5e+00
—
—
—
—
—
cases:1.58%
controls:0.55%
cases:1.58%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
6
21
373
3769
6
5
373
3785
—
—
—
—
—
Lumbar spine X-ray examination without contrast
NA3AA [2001307026]
NA3AA [2001307026]
3.4e-01
2.5e+00
—
—
—
—
—
cases:1.85%
controls:1.32%
cases:1.58%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
7
50
372
3740
6
5
373
3785
—
—
—
—
—
Post-traumatic wound infection, not elsewhere classified
T79.3 [45537002]
T79.3 [45537002]
2.5e+00
—
—
—
—
—
—
cases:1.58%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
—
—
6
5
373
3785
—
—
—
—
—
—
desonide
D07AB08 [21602112]
D07AB08 [21602112]
1.0e+00
1.5e+00
—
—
—
—
6.8e-01
cases:4.75%
controls:1.79%
cases:2.64%
controls:0.61%
—
—
—
—
—
—
—
—
cases:3.23%
controls:1.67%
18
68
361
3722
10
23
369
3767
—
—
—
—
8
43
240
2537
Fall on same level involving ice and snow
W00 [45756242]
W00 [45756242]
1.6e-01
—
—
1.0e+50
—
2.5e+00
5.1e-01
cases:1.58%
controls:1.35%
—
—
—
—
cases:1.32%
controls:0.00%
—
—
cases:2.34%
controls:0.20%
cases:2.42%
controls:1.47%
6
51
373
3739
—
—
5
0
374
3790
—
8
7
334
3543
6
38
242
2542
No disease
A97 [2002000230]
A97 [2002000230]
3.9e-01
1.5e+00
—
—
-1.0e+50
5.1e-01
1.0e+00
cases:3.96%
controls:2.72%
cases:3.43%
controls:0.82%
—
—
—
—
cases:0.00%
controls:0.34%
cases:2.05%
controls:1.24%
cases:9.68%
controls:3.76%
15
103
364
3687
13
31
366
3759
—
—
0
13
377
3758
7
44
335
3506
24
97
224
2483
Potassium [Moles/volume] in Arterial blood
32713-0 [3043409]
32713-0 [3043409]
—
2.5e+00
—
—
—
—
—
—
—
cases:2.11%
controls:0.18%
—
—
—
—
—
—
—
—
—
—
—
8
7
371
3783
—
—
—
—
—
Lactate [Moles/volume] in Arterial blood
2518-9 [3018405]
2518-9 [3018405]
3.6e-01
2.4e+00
—
—
—
—
—
cases:1.32%
controls:0.92%
cases:2.37%
controls:0.21%
—
—
—
—
—
—
—
—
—
—
5
35
374
3755
9
8
370
3782
—
—
—
—
—
pH of Venous blood
2746-6 [3012544]
2746-6 [3012544]
8.1e-01
1.6e+00
—
—
—
6.8e-01
8.1e-01
cases:6.33%
controls:2.93%
cases:4.75%
controls:1.03%
—
—
—
—
—
—
cases:2.63%
controls:1.35%
cases:7.66%
controls:3.57%
24
111
355
3679
18
39
361
3751
—
—
—
9
48
333
3502
19
92
229
2488
disulfiram; oral
N07BB01 [21604821]
N07BB01 [21604821]
1.6e+00
—
—
—
—
—
2.4e+00
cases:1.85%
controls:0.37%
—
—
—
—
—
—
—
—
—
—
cases:2.82%
controls:0.27%
7
14
372
3776
—
—
—
—
—
7
7
241
2573
Revision of wound of skin of lower limb
QDB05 [2001309969]
QDB05 [2001309969]
1.3e+00
—
—
1.0e+50
1.0e+50
—
2.4e+00
cases:1.32%
controls:0.37%
—
—
—
—
cases:2.90%
controls:0.00%
cases:2.65%
controls:0.00%
—
—
cases:2.42%
controls:0.23%
5
14
374
3776
—
—
11
0
368
3790
10
0
367
3771
—
6
6
242
2574
prednisolone
A07EA01 [21600653]
A07EA01 [21600653]
7.7e-01
8.5e-01
1.0e+00
—
9.3e-01
6.8e-01
7.3e-01
cases:22.69%
controls:11.95%
cases:11.08%
controls:5.04%
cases:3.17%
controls:1.13%
—
—
cases:2.12%
controls:0.85%
cases:9.06%
controls:4.79%
cases:19.76%
controls:10.62%
86
453
293
3337
42
191
337
3599
12
43
367
3747
—
8
32
369
3739
31
170
311
3380
49
274
199
2306
Alcoholic cirrhosis of liver
K70.3 [45596343]
K70.3 [45596343]
—
—
—
—
—
2.4e+00
—
—
—
—
—
—
—
—
—
—
—
cases:1.46%
controls:0.14%
—
—
—
—
—
—
—
5
5
337
3545
—
Emotionally unstable personality disorder, impulsive
F60.30 [2000502022]
F60.30 [2000502022]
—
—
—
—
—
2.4e+00
—
—
—
—
—
—
—
—
—
—
—
cases:1.46%
controls:0.14%
—
—
—
—
—
—
—
5
5
337
3545
—
Care involving use of rehabilitation procedure, unspecified
Z50.9 [45595525]
Z50.9 [45595525]
—
-1.0e+50
—
—
—
2.4e+00
—
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
cases:1.46%
controls:0.14%
—
—
—
0
5
379
3785
—
—
—
5
5
337
3545
—
Overall medication plan or its review
SPAT1252 [2001700353]
SPAT1252 [2001700353]
1.3e+00
2.3e+00
—
—
—
—
—
cases:2.64%
controls:0.71%
cases:1.85%
controls:0.18%
—
—
—
—
—
—
—
—
—
—
10
27
369
3763
7
7
372
3783
—
—
—
—
—
Recurrent depression, moderate episode of somatic syndrome
F33.11 [2000501985]
F33.11 [2000501985]
2.3e+00
—
—
—
—
—
—
cases:1.85%
controls:0.18%
—
—
—
—
—
—
—
—
—
—
—
—
7
7
372
3783
—
—
—
—
—
—
Open wound of knee
S81.0 [45545633]
S81.0 [45545633]
2.3e+00
—
—
—
—
—
—
cases:1.58%
controls:0.16%
—
—
—
—
—
—
—
—
—
—
—
—
6
6
373
3784
—
—
—
—
—
—
Medical doctor
Z2221 [2001311556]
Z2221 [2001311556]
8.2e-01
—
—
—
—
—
1.5e+00
cases:6.33%
controls:2.90%
—
—
—
—
—
—
—
—
—
—
cases:5.65%
controls:1.32%
24
110
355
3680
—
—
—
—
—
14
34
234
2546
Infectious Disease
44 [38004484]
44 [38004484]
8.7e-01
8.1e-01
-1.0e+50
—
—
9.6e-01
1.4e+00
cases:5.54%
controls:2.40%
cases:2.11%
controls:0.95%
cases:0.00%
controls:0.13%
—
—
—
—
cases:1.75%
controls:0.68%
cases:7.26%
controls:1.90%
21
91
358
3699
8
36
371
3754
0
5
379
3785
—
—
6
24
336
3526
18
49
230
2531
Partial excision of meniscus of knee, arthroscopic
NGD05 [2001308109]
NGD05 [2001308109]
—
—
—
—
—
-1.0e+50
2.2e+00
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.20%
cases:4.84%
controls:0.54%
—
—
—
—
—
0
7
342
3543
12
14
236
2566
clobetasol
D07AD01 [21602141]
D07AD01 [21602141]
9.2e-01
9.6e-01
-1.0e+50
—
—
1.3e+00
5.9e-01
cases:5.80%
controls:2.40%
cases:2.90%
controls:1.13%
cases:0.00%
controls:0.18%
—
—
—
—
cases:3.80%
controls:1.07%
cases:5.24%
controls:2.98%
22
91
357
3699
11
43
368
3747
0
7
379
3783
—
—
13
38
329
3512
13
77
235
2503
Contusion of knee
S80.0 [45569633]
S80.0 [45569633]
1.1e+00
1.6e+00
—
—
—
2.2e+00
9.4e-01
cases:2.37%
controls:0.79%
cases:1.58%
controls:0.32%
—
—
—
—
—
—
cases:1.75%
controls:0.20%
cases:3.23%
controls:1.28%
9
30
370
3760
6
12
373
3778
—
—
—
6
7
336
3543
8
33
240
2547
Treatment of reopened or infected surgical wound
SPAT1144 [2001700245]
SPAT1144 [2001700245]
6.1e-01
—
—
—
—
2.2e+00
—
cases:2.11%
controls:1.16%
—
—
—
—
—
—
—
—
cases:1.75%
controls:0.20%
—
—
8
44
371
3746
—
—
—
—
6
7
336
3543
—
Shoulder X-ray examination without contrast
NB1AA [2001307225]
NB1AA [2001307225]
6.7e-01
1.4e+00
—
—
—
2.2e+00
9.8e-01
cases:1.58%
controls:0.82%
cases:1.32%
controls:0.34%
—
—
—
—
—
—
cases:1.75%
controls:0.20%
cases:3.63%
controls:1.40%
6
31
373
3759
5
13
374
3777
—
—
—
6
7
336
3543
9
36
239
2544
Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54067-4 [3051552]
54067-4 [3051552]
9.3e-01
—
—
—
—
—
1.3e+00
cases:4.49%
controls:1.82%
—
—
—
—
—
—
—
—
—
—
cases:6.45%
controls:1.90%
17
69
362
3721
—
—
—
—
—
16
49
232
2531
Respiratory and circulatory monitoring
WX700 [2001310817]
WX700 [2001310817]
9.1e-01
7.0e-01
—
1.0e+50
—
—
1.3e+00
cases:5.01%
controls:2.08%
cases:1.32%
controls:0.66%
—
—
cases:1.58%
controls:0.00%
—
—
—
—
cases:5.65%
controls:1.67%
19
79
360
3711
5
25
374
3765
—
6
0
373
3790
—
—
14
43
234
2537
Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
21573-1 [3003031]
21573-1 [3003031]
8.0e-01
1.4e+00
—
—
—
3.5e-01
2.7e-01
cases:8.97%
controls:4.25%
cases:3.69%
controls:0.98%
—
—
—
—
—
—
cases:1.75%
controls:1.24%
cases:4.03%
controls:3.10%
34
161
345
3629
14
37
365
3753
—
—
—
6
44
336
3506
10
80
238
2500
alfacalcidol; oral, parenteral
A11CC03 [21600818]
A11CC03 [21600818]
1.3e+00
2.1e+00
—
—
-1.0e+50
1.8e+00
—
cases:1.58%
controls:0.45%
cases:2.11%
controls:0.26%
—
—
—
—
cases:0.00%
controls:0.19%
cases:1.75%
controls:0.28%
—
—
6
17
373
3773
8
10
371
3780
—
—
0
7
377
3764
6
10
336
3540
—
Striking against or struck by other object(s)
W22 [45756260]
W22 [45756260]
1.0e+00
1.4e+00
—
1.0e+50
—
2.1e+00
—
cases:1.85%
controls:0.69%
cases:1.32%
controls:0.32%
—
—
cases:4.49%
controls:0.00%
—
—
cases:1.75%
controls:0.23%
—
—
7
26
372
3764
5
12
374
3778
—
17
0
362
3790
—
6
8
336
3542
—
C reactive protein [Mass/volume] in Body fluid
16503-5 [3035320]
16503-5 [3035320]
2.1e+00
—
—
—
—
—
—
cases:1.85%
controls:0.24%
—
—
—
—
—
—
—
—
—
—
—
—
7
9
372
3781
—
—
—
—
—
—
temazepam; oral
N05CD07 [21604642]
N05CD07 [21604642]
6.7e-01
9.9e-01
1.4e+00
—
—
1.1e+00
7.1e-01
cases:5.80%
controls:3.06%
cases:4.49%
controls:1.72%
cases:1.58%
controls:0.40%
—
—
—
—
cases:4.39%
controls:1.58%
cases:4.84%
controls:2.44%
22
116
357
3674
17
65
362
3725
6
15
373
3775
—
—
15
56
327
3494
12
63
236
2517
Hemodialysis
TK800 [2001305768]
TK800 [2001305768]
2.0e+00
—
—
—
—
—
—
cases:1.58%
controls:0.21%
—
—
—
—
—
—
—
—
—
—
—
—
6
8
373
3782
—
—
—
—
—
—
Mechanical complication of internal joint prosthesis
T84.0 [45570736]
T84.0 [45570736]
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
cases:2.05%
controls:0.28%
—
—
—
—
—
—
—
7
10
335
3540
—
allopurinol; oral, parenteral
M04AA01 [21604131]
M04AA01 [21604131]
9.2e-01
6.0e-01
8.1e-01
—
3.9e-01
5.9e-01
1.1e+00
cases:6.07%
controls:2.51%
cases:3.96%
controls:2.22%
cases:1.58%
controls:0.71%
—
—
cases:1.33%
controls:0.90%
cases:3.80%
controls:2.14%
cases:7.66%
controls:2.79%
23
95
356
3695
15
84
364
3706
6
27
373
3763
—
5
34
372
3737
13
76
329
3474
19
72
229
2508
amoxicillin and beta-lactamase inhibitor; oral, parenteral
J01CR02 [21602863]
J01CR02 [21602863]
4.7e-01
4.0e-01
—
—
2.0e+00
2.8e-01
6.0e-01
cases:12.40%
controls:8.13%
cases:3.96%
controls:2.69%
—
—
—
—
cases:1.86%
controls:0.27%
cases:3.22%
controls:2.45%
cases:13.71%
controls:7.98%
47
308
332
3482
15
102
364
3688
—
—
7
10
370
3761
11
87
331
3463
34
206
214
2374
levomepromazine; oral, parenteral
N05AA02 [21604493]
N05AA02 [21604493]
2.0e+00
—
—
—
—
—
—
cases:1.85%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
—
—
7
10
372
3780
—
—
—
—
—
—
calcium (different salts in combination); oral
A12AA20 [21600872]
A12AA20 [21600872]
5.0e-01
6.8e-01
6.1e-01
—
6.3e-01
6.0e-01
6.8e-01
cases:15.57%
controls:10.03%
cases:14.78%
controls:8.10%
cases:4.49%
controls:2.48%
—
—
cases:3.71%
controls:2.02%
cases:13.45%
controls:7.89%
cases:18.55%
controls:10.31%
59
380
320
3410
56
307
323
3483
17
94
362
3696
—
14
76
363
3695
46
280
296
3270
46
266
202
2314
Carboxyhemoglobin/Hemoglobin.total in Blood
20563-3 [3023081]
20563-3 [3023081]
6.7e-01
1.9e+00
—
—
—
—
5.9e-01
cases:1.85%
controls:0.95%
cases:2.11%
controls:0.32%
—
—
—
—
—
—
—
—
cases:2.02%
controls:1.12%
7
36
372
3754
8
12
371
3778
—
—
—
—
5
29
243
2551
Hospital outpatient
ZY010 [2001311599]
ZY010 [2001311599]
5.7e-01
—
—
—
—
—
1.9e+00
cases:1.58%
controls:0.90%
—
—
—
—
—
—
—
—
—
—
cases:2.82%
controls:0.43%
6
34
373
3756
—
—
—
—
—
7
11
241
2569
Other hammer toe(s) (acquired)
M20.4 [45562664]
M20.4 [45562664]
1.9e+00
—
—
—
—
—
—
cases:1.85%
controls:0.29%
—
—
—
—
—
—
—
—
—
—
—
—
7
11
372
3779
—
—
—
—
—
—
Poisoning by systemic antibiotics
T36 [45756588]
T36 [45756588]
1.9e+00
—
—
—
—
2.2e+00
2.2e+00
cases:2.64%
controls:0.42%
—
—
—
—
—
—
—
—
cases:1.46%
controls:0.17%
cases:2.02%
controls:0.23%
10
16
369
3774
—
—
—
—
5
6
337
3544
5
6
243
2574
Migraine with aura [classical migraine]
G43.1 [45562086]
G43.1 [45562086]
1.0e+00
1.8e+00
—
—
—
1.1e+00
1.3e+00
cases:2.37%
controls:0.84%
cases:2.11%
controls:0.34%
—
—
—
—
—
—
cases:1.75%
controls:0.62%
cases:3.23%
controls:0.89%
9
32
370
3758
8
13
371
3777
—
—
—
6
22
336
3528
8
23
240
2557
Open wound of other parts of lower leg
S81.8 [45564809]
S81.8 [45564809]
1.8e+00
—
—
—
1.0e+50
—
2.0e+00
cases:2.11%
controls:0.34%
—
—
—
—
—
—
cases:1.86%
controls:0.00%
—
—
cases:2.02%
controls:0.27%
8
13
371
3777
—
—
—
7
0
370
3771
—
5
7
243
2573
Suture or treatment of traumatic wound
SPAT1149 [2001700250]
SPAT1149 [2001700250]
3.9e-01
1.2e+00
—
—
—
1.8e+00
8.1e-01
cases:3.43%
controls:2.35%
cases:1.58%
controls:0.47%
—
—
—
—
—
—
cases:2.92%
controls:0.48%
cases:2.82%
controls:1.28%
13
89
366
3701
6
18
373
3772
—
—
—
10
17
332
3533
7
33
241
2547
Derangement of meniscus due to old tear or injury
M23.2 [45591779]
M23.2 [45591779]
—
-1.0e+50
—
—
—
—
1.8e+00
—
—
cases:0.00%
controls:0.24%
—
—
—
—
—
—
—
—
cases:2.82%
controls:0.47%
—
0
9
379
3781
—
—
—
—
7
12
241
2568
General anaesthesia
WX402 [2001310806]
WX402 [2001310806]
6.5e-01
9.7e-01
—
—
1.4e+00
7.2e-01
8.5e-01
cases:7.39%
controls:4.01%
cases:4.75%
controls:1.85%
—
—
—
—
cases:1.33%
controls:0.32%
cases:2.63%
controls:1.30%
cases:9.27%
controls:4.19%
28
152
351
3638
18
70
361
3720
—
—
5
12
372
3759
9
46
333
3504
23
108
225
2472
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
2601-3 [3012095]
8.6e-01
9.6e-01
-1.0e+50
—
—
8.4e-01
5.3e-01
cases:9.23%
controls:4.12%
cases:4.49%
controls:1.77%
cases:0.00%
controls:0.13%
—
—
—
—
cases:4.39%
controls:1.94%
cases:6.85%
controls:4.15%
35
156
344
3634
17
67
362
3723
0
5
379
3785
—
—
15
69
327
3481
17
107
231
2473
Reticulocytes/Erythrocytes in Blood
4679-7 [3027945]
4679-7 [3027945]
7.8e-01
1.0e+00
—
—
—
8.1e-01
5.4e-01
cases:7.12%
controls:3.40%
cases:3.69%
controls:1.35%
—
—
—
—
—
—
cases:2.92%
controls:1.32%
cases:5.65%
controls:3.37%
27
129
352
3661
14
51
365
3739
—
—
—
10
47
332
3503
14
87
234
2493
Hemoglobin [Mass/volume] in Venous blood
30350-3 [3004119]
30350-3 [3004119]
6.8e-01
1.8e+00
—
—
—
6.6e-01
7.4e-01
cases:3.43%
controls:1.77%
cases:2.64%
controls:0.45%
—
—
—
—
—
—
cases:1.46%
controls:0.76%
cases:4.44%
controls:2.17%
13
67
366
3723
10
17
369
3773
—
—
—
5
27
337
3523
11
56
237
2524
Methemoglobin/Hemoglobin.total in Blood
2614-6 [3007930]
2614-6 [3007930]
7.0e-01
1.8e+00
—
—
—
—
6.7e-01
cases:1.85%
controls:0.92%
cases:1.85%
controls:0.32%
—
—
—
—
—
—
—
—
cases:2.02%
controls:1.05%
7
35
372
3755
7
12
372
3778
—
—
—
—
5
27
243
2553
Cell count panel - Synovial fluid
34559-5 [3044941]
34559-5 [3044941]
1.8e+00
—
—
—
—
—
—
cases:1.85%
controls:0.32%
—
—
—
—
—
—
—
—
—
—
—
—
7
12
372
3778
—
—
—
—
—
—
Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
19258-3 [3004529]
19258-3 [3004529]
6.2e-01
1.8e+00
—
—
—
—
5.4e-01
cases:2.37%
controls:1.29%
cases:2.11%
controls:0.37%
—
—
—
—
—
—
—
—
cases:2.82%
controls:1.67%
9
49
370
3741
8
14
371
3776
—
—
—
—
7
43
241
2537
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
X69 [45585661]
X69 [45585661]
1.8e+00
—
—
—
—
—
—
cases:2.11%
controls:0.37%
—
—
—
—
—
—
—
—
—
—
—
—
8
14
371
3776
—
—
—
—
—
—
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
2705-2 [3024354]
7.8e-01
1.7e+00
—
—
—
6.3e-01
8.7e-01
cases:4.75%
controls:2.24%
cases:4.22%
controls:0.77%
—
—
—
—
—
—
cases:2.05%
controls:1.10%
cases:6.85%
controls:2.98%
18
85
361
3705
16
29
363
3761
—
—
—
7
39
335
3511
17
77
231
2503
Bicarbonate [Moles/volume] in Arterial blood
1960-4 [3008152]
1960-4 [3008152]
3.5e-01
1.7e+00
—
—
—
8.7e-01
7.8e-01
cases:2.11%
controls:1.50%
cases:2.64%
controls:0.47%
—
—
—
—
—
—
cases:1.46%
controls:0.62%
cases:2.82%
controls:1.32%
8
57
371
3733
10
18
369
3772
—
—
—
5
22
337
3528
7
34
241
2546
Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
50796-2 [3029338]
50796-2 [3029338]
1.7e+00
1.3e+00
—
—
—
—
1.2e+00
cases:3.69%
controls:0.69%
cases:1.32%
controls:0.37%
—
—
—
—
—
—
—
—
cases:2.42%
controls:0.78%
14
26
365
3764
5
14
374
3776
—
—
—
—
6
20
242
2560
Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
50797-0 [3029379]
50797-0 [3029379]
1.7e+00
1.3e+00
—
—
—
—
1.3e+00
cases:3.69%
controls:0.69%
cases:1.32%
controls:0.37%
—
—
—
—
—
—
—
—
cases:2.42%
controls:0.70%
14
26
365
3764
5
14
374
3776
—
—
—
—
6
18
242
2562
Neurology
13 [38004458]
13 [38004458]
8.1e-01
5.9e-01
5.9e-01
—
1.1e+00
5.0e-01
9.0e-01
cases:19.00%
controls:9.42%
cases:6.86%
controls:3.93%
cases:1.32%
controls:0.74%
—
—
cases:1.86%
controls:0.61%
cases:6.73%
controls:4.20%
cases:18.95%
controls:8.72%
72
357
307
3433
26
149
353
3641
5
28
374
3762
—
7
23
370
3748
23
149
319
3401
47
225
201
2355
Hepatitis B virus core IgM Ab [Presence] in Serum
31204-1 [3013527]
31204-1 [3013527]
1.7e+00
—
—
—
—
—
—
cases:2.64%
controls:0.50%
—
—
—
—
—
—
—
—
—
—
—
—
10
19
369
3771
—
—
—
—
—
—
Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
35559-4 [3035797]
35559-4 [3035797]
1.7e+00
1.2e+00
—
—
—
—
1.1e+00
cases:3.96%
controls:0.77%
cases:1.32%
controls:0.40%
—
—
—
—
—
—
—
—
cases:2.42%
controls:0.81%
15
29
364
3761
5
15
374
3775
—
—
—
—
6
21
242
2559
pantoprazole; oral, parenteral
A02BC02 [21600097]
A02BC02 [21600097]
3.1e-01
5.6e-01
7.5e-01
—
5.9e-01
5.1e-01
6.0e-01
cases:25.86%
controls:20.37%
cases:18.73%
controls:11.66%
cases:6.07%
controls:2.96%
—
—
cases:5.04%
controls:2.86%
cases:20.18%
controls:13.15%
cases:31.85%
controls:20.39%
98
772
281
3018
71
442
308
3348
23
112
356
3678
—
19
108
358
3663
69
467
273
3083
79
526
169
2054
Cathetrisation of vein
TPH04 [2001309597]
TPH04 [2001309597]
7.4e-01
9.2e-01
—
1.0e+50
—
1.2e+00
9.3e-01
cases:7.92%
controls:3.93%
cases:3.43%
controls:1.40%
—
—
cases:1.85%
controls:0.00%
—
—
cases:3.51%
controls:1.13%
cases:7.66%
controls:3.18%
30
149
349
3641
13
53
366
3737
—
7
0
372
3790
—
12
40
330
3510
19
82
229
2498
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
19875-4 [3001668]
5.2e-01
1.6e+00
—
—
—
1.0e+00
7.5e-01
cases:4.49%
controls:2.72%
cases:2.11%
controls:0.42%
—
—
—
—
—
—
cases:1.46%
controls:0.54%
cases:2.42%
controls:1.16%
17
103
362
3687
8
16
371
3774
—
—
—
5
19
337
3531
6
30
242
2550
FEV1/FVC --post bronchodilation
69970-2 [42868459]
69970-2 [42868459]
5.2e-01
1.6e+00
—
—
—
1.0e+00
7.5e-01
cases:4.49%
controls:2.72%
cases:2.11%
controls:0.42%
—
—
—
—
—
—
cases:1.46%
controls:0.54%
cases:2.42%
controls:1.16%
17
103
362
3687
8
16
371
3774
—
—
—
5
19
337
3531
6
30
242
2550
FVC percent change Respiratory system
69982-7 [42868471]
69982-7 [42868471]
5.2e-01
1.6e+00
—
—
—
1.0e+00
7.5e-01
cases:4.49%
controls:2.72%
cases:2.11%
controls:0.42%
—
—
—
—
—
—
cases:1.46%
controls:0.54%
cases:2.42%
controls:1.16%
17
103
362
3687
8
16
371
3774
—
—
—
5
19
337
3531
6
30
242
2550
FEV1 percent change
69983-5 [42868472]
69983-5 [42868472]
5.2e-01
1.6e+00
—
—
—
1.0e+00
7.5e-01
cases:4.49%
controls:2.72%
cases:2.11%
controls:0.42%
—
—
—
—
—
—
cases:1.46%
controls:0.54%
cases:2.42%
controls:1.16%
17
103
362
3687
8
16
371
3774
—
—
—
5
19
337
3531
6
30
242
2550
FEV1 --post bronchodilation
20155-8 [3023550]
20155-8 [3023550]
5.2e-01
1.6e+00
—
—
—
1.0e+00
7.5e-01
cases:4.49%
controls:2.72%
cases:2.11%
controls:0.42%
—
—
—
—
—
—
cases:1.46%
controls:0.54%
cases:2.42%
controls:1.16%
17
103
362
3687
8
16
371
3774
—
—
—
5
19
337
3531
6
30
242
2550
Bacteria identified in Urine by Culture
630-4 [3026008]
630-4 [3026008]
4.2e-01
9.8e-01
1.1e+00
—
1.2e+00
5.6e-01
6.4e-01
cases:13.46%
controls:9.29%
cases:9.23%
controls:3.67%
cases:1.85%
controls:0.63%
—
—
cases:1.86%
controls:0.58%
cases:7.89%
controls:4.68%
cases:16.13%
controls:9.22%
51
352
328
3438
35
139
344
3651
7
24
372
3766
—
7
22
370
3749
27
166
315
3384
40
238
208
2342
Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
51435-6 [3029713]
51435-6 [3029713]
1.6e+00
1.1e+00
—
—
—
—
7.5e-01
cases:3.96%
controls:0.82%
cases:1.32%
controls:0.45%
—
—
—
—
—
—
—
—
cases:2.42%
controls:1.16%
15
31
364
3759
5
17
374
3773
—
—
—
—
6
30
242
2550
Assessment of need for services (elderly/care support)
SPAT1217 [2001700318]
SPAT1217 [2001700318]
6.8e-01
—
—
—
—
1.6e+00
—
cases:2.37%
controls:1.21%
—
—
—
—
—
—
—
—
cases:2.34%
controls:0.48%
—
—
9
46
370
3744
—
—
—
—
8
17
334
3533
—
Gas panel - Arterial blood
24336-0 [3019060]
24336-0 [3019060]
4.7e-01
1.3e+00
—
—
—
1.6e+00
1.2e+00
cases:2.64%
controls:1.66%
cases:1.85%
controls:0.50%
—
—
—
—
—
—
cases:2.34%
controls:0.48%
cases:2.82%
controls:0.85%
10
63
369
3727
7
19
372
3771
—
—
—
8
17
334
3533
7
22
241
2558
Myeloperoxidase IgG Ab [Units/volume] in Serum
48404-8 [3049804]
48404-8 [3049804]
1.6e+00
—
—
—
—
—
—
cases:3.43%
controls:0.71%
—
—
—
—
—
—
—
—
—
—
—
—
13
27
366
3763
—
—
—
—
—
—
Hepatitis B virus core and surface Ab and surface Ag panel - Serum
77190-7 [46237023]
77190-7 [46237023]
1.6e+00
1.5e+00
—
—
—
1.9e+00
—
cases:4.49%
controls:0.95%
cases:1.58%
controls:0.37%
—
—
—
—
—
—
cases:1.46%
controls:0.23%
—
—
17
36
362
3754
6
14
373
3776
—
—
—
5
8
337
3542
—
Type 2 diabetes mellitus, with multiple complications
E11.7 [45561950]
E11.7 [45561950]
1.2e+00
—
—
—
—
1.5e+00
1.6e+00
cases:1.85%
controls:0.58%
—
—
—
—
—
—
—
—
cases:1.75%
controls:0.39%
cases:4.03%
controls:0.85%
7
22
372
3768
—
—
—
—
6
14
336
3536
10
22
238
2558
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
33762-6 [3029187]
33762-6 [3029187]
7.3e-01
8.5e-01
1.1e+00
—
1.0e+00
2.6e-02
3.9e-01
cases:14.25%
controls:7.44%
cases:9.50%
controls:4.27%
cases:1.85%
controls:0.63%
—
—
cases:2.12%
controls:0.77%
cases:4.68%
controls:4.56%
cases:14.11%
controls:10.04%
54
282
325
3508
36
162
343
3628
7
24
372
3766
—
8
29
369
3742
16
162
326
3388
35
259
213
2321
ibuprofen
R02AX02 [1588667]
R02AX02 [1588667]
2.7e-02
3.0e-01
5.4e-01
—
1.6e+00
3.9e-01
2.5e-01
cases:35.62%
controls:35.01%
cases:19.26%
controls:15.07%
cases:3.43%
controls:2.03%
—
—
cases:7.96%
controls:1.75%
cases:21.05%
controls:15.27%
cases:38.31%
controls:32.56%
135
1327
244
2463
73
571
306
3219
13
77
366
3713
—
30
66
347
3705
72
542
270
3008
95
840
153
1740
ibuprofen; oral, parenteral, rectal
M01AE01 [21603967]
M01AE01 [21603967]
2.7e-02
3.0e-01
5.4e-01
—
1.6e+00
3.9e-01
2.5e-01
cases:35.62%
controls:35.01%
cases:19.26%
controls:15.07%
cases:3.43%
controls:2.03%
—
—
cases:7.96%
controls:1.75%
cases:21.05%
controls:15.27%
cases:38.31%
controls:32.56%
135
1327
244
2463
73
571
306
3219
13
77
366
3713
—
30
66
347
3705
72
542
270
3008
95
840
153
1740
Hematology
82 [38004501]
82 [38004501]
1.6e+00
1.2e+00
—
—
—
1.1e+00
8.7e-01
cases:5.28%
controls:1.16%
cases:2.37%
controls:0.74%
—
—
—
—
—
—
cases:2.05%
controls:0.70%
cases:3.63%
controls:1.55%
20
44
359
3746
9
28
370
3762
—
—
—
7
25
335
3525
9
40
239
2540
Skin texture symptom/complaint
S21 [2002000986]
S21 [2002000986]
7.0e-01
9.1e-01
—
—
—
1.6e+00
6.3e-01
cases:4.22%
controls:2.14%
cases:2.64%
controls:1.08%
—
—
—
—
—
—
cases:4.39%
controls:0.96%
cases:5.24%
controls:2.87%
16
81
363
3709
10
41
369
3749
—
—
—
15
34
327
3516
13
74
235
2506
Feeling depressed
P03 [2002000800]
P03 [2002000800]
8.7e-01
—
—
—
—
—
1.5e+00
cases:3.17%
controls:1.35%
—
—
—
—
—
—
—
—
—
—
cases:5.24%
controls:1.16%
12
51
367
3739
—
—
—
—
—
13
30
235
2550
pH of Urine
2756-5 [3015736]
2756-5 [3015736]
2.9e-01
5.2e-01
7.6e-01
—
1.5e+00
3.4e-01
2.7e-01
cases:16.89%
controls:13.19%
cases:9.50%
controls:5.86%
cases:1.85%
controls:0.87%
—
—
cases:3.71%
controls:0.82%
cases:8.48%
controls:6.17%
cases:18.95%
controls:15.16%
64
500
315
3290
36
222
343
3568
7
33
372
3757
—
14
31
363
3740
29
219
313
3331
47
391
201
2189
olanzapine; oral, parenteral
N05AH03 [21604543]
N05AH03 [21604543]
7.3e-01
1.0e+00
—
—
—
1.5e+00
6.5e-01
cases:2.37%
controls:1.16%
cases:1.85%
controls:0.69%
—
—
—
—
—
—
cases:2.92%
controls:0.65%
cases:2.42%
controls:1.28%
9
44
370
3746
7
26
372
3764
—
—
—
10
23
332
3527
6
33
242
2547
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
25428-4 [3009261]
2.5e-01
4.2e-01
7.0e-01
—
1.5e+00
2.1e-01
2.8e-01
cases:20.84%
controls:16.97%
cases:11.87%
controls:8.13%
cases:2.11%
controls:1.06%
—
—
cases:5.04%
controls:1.14%
cases:10.82%
controls:8.99%
cases:25.00%
controls:20.08%
79
643
300
3147
45
308
334
3482
8
40
371
3750
—
19
43
358
3728
37
319
305
3231
62
518
186
2062
Dedicated profession-specific psychiatric intervention, individual
IEY05 [2001304224]
IEY05 [2001304224]
1.5e+00
1.1e+00
—
—
-1.0e+50
—
—
cases:2.37%
controls:0.53%
cases:1.32%
controls:0.42%
—
—
—
—
cases:0.00%
controls:0.16%
—
—
—
—
9
20
370
3770
5
16
374
3774
—
—
0
6
377
3765
—
—
X-ray examination of the lungs in one projection
GD1PA [2001303645]
GD1PA [2001303645]
1.0e+00
1.3e+00
—
—
—
1.5e+00
1.5e+00
cases:2.64%
controls:0.95%
cases:1.32%
controls:0.37%
—
—
—
—
—
—
cases:1.46%
controls:0.34%
cases:5.24%
controls:1.20%
10
36
369
3754
5
14
374
3776
—
—
—
5
12
337
3538
13
31
235
2549
Counselling and guidance related to nutrition and weight management
SPAT1306 [2001700407]
SPAT1306 [2001700407]
3.5e-01
4.5e-01
1.2e+00
—
1.1e+00
1.5e+00
4.3e-01
cases:3.17%
controls:2.24%
cases:1.32%
controls:0.84%
cases:1.32%
controls:0.40%
—
—
cases:1.33%
controls:0.45%
cases:3.22%
controls:0.73%
cases:2.82%
controls:1.86%
12
85
367
3705
5
32
374
3758
5
15
374
3775
—
5
17
372
3754
11
26
331
3524
7
48
241
2532
Hemoglobin [Presence] in Urine by Test strip
5794-3 [3011397]
5794-3 [3011397]
3.8e-01
6.8e-01
—
—
1.5e+00
6.5e-01
4.2e-01
cases:10.55%
controls:7.49%
cases:7.12%
controls:3.75%
—
—
—
—
cases:2.92%
controls:0.66%
cases:7.31%
controls:3.97%
cases:13.31%
controls:9.15%
40
284
339
3506
27
142
352
3648
—
—
11
25
366
3746
25
141
317
3409
33
236
215
2344
tizanidine; oral
M03BX02 [21604116]
M03BX02 [21604116]
4.7e-01
7.5e-01
1.3e+00
—
—
7.5e-01
5.2e-01
cases:18.21%
controls:12.22%
cases:7.39%
controls:3.64%
cases:2.11%
controls:0.61%
—
—
—
—
cases:7.89%
controls:3.89%
cases:18.55%
controls:11.90%
69
463
310
3327
28
138
351
3652
8
23
371
3767
—
—
27
138
315
3412
46
307
202
2273
Weakness/tiredness general
A04 [2002000145]
A04 [2002000145]
1.6e-01
1.5e+00
—
—
—
8.2e-01
2.0e-01
cases:3.17%
controls:2.72%
cases:3.96%
controls:0.92%
—
—
—
—
—
—
cases:2.34%
controls:1.04%
cases:4.44%
controls:3.64%
12
103
367
3687
15
35
364
3755
—
—
—
8
37
334
3513
11
94
237
2486
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
2514-8 [3035350]
2.6e-01
4.6e-01
5.7e-01
—
1.5e+00
2.2e-01
2.6e-01
cases:20.58%
controls:16.62%
cases:12.14%
controls:8.02%
cases:1.85%
controls:1.06%
—
—
cases:5.04%
controls:1.19%
cases:11.11%
controls:9.15%
cases:24.60%
controls:20.04%
78
630
301
3160
46
304
333
3486
7
40
372
3750
—
19
45
358
3726
38
325
304
3225
61
517
187
2063
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
19870-5 [3020158]
4.6e-01
1.5e+00
—
—
—
9.6e-01
5.9e-01
cases:4.75%
controls:3.06%
cases:2.37%
controls:0.55%
—
—
—
—
—
—
cases:1.75%
controls:0.68%
cases:2.82%
controls:1.59%
18
116
361
3674
9
21
370
3769
—
—
—
6
24
336
3526
7
41
241
2539
FEV1
20150-9 [3024653]
20150-9 [3024653]
4.6e-01
1.5e+00
—
—
—
9.6e-01
5.9e-01
cases:4.75%
controls:3.06%
cases:2.37%
controls:0.55%
—
—
—
—
—
—
cases:1.75%
controls:0.68%
cases:2.82%
controls:1.59%
18
116
361
3674
9
21
370
3769
—
—
—
6
24
336
3526
7
41
241
2539
Type 1 diabetes mellitus, With multiple complications
E10.7 [45571655]
E10.7 [45571655]
1.5e+00
1.6e+00
1.8e+00
—
—
1.5e+00
—
cases:2.37%
controls:0.55%
cases:1.85%
controls:0.40%
cases:1.32%
controls:0.21%
—
—
—
—
cases:2.05%
controls:0.48%
—
—
9
21
370
3769
7
15
372
3775
5
8
374
3782
—
—
7
17
335
3533
—
FEV1/FVC
19926-5 [3011505]
19926-5 [3011505]
4.6e-01
1.5e+00
—
—
—
9.6e-01
5.9e-01
cases:4.75%
controls:3.06%
cases:2.37%
controls:0.55%
—
—
—
—
—
—
cases:1.75%
controls:0.68%
cases:2.82%
controls:1.59%
18
116
361
3674
9
21
370
3769
—
—
—
6
24
336
3526
7
41
241
2539
methylprednisolone; oral, parenteral
H02AB04 [21602732]
H02AB04 [21602732]
8.6e-01
1.5e+00
—
—
—
1.3e+00
1.2e+00
cases:3.43%
controls:1.48%
cases:2.37%
controls:0.55%
—
—
—
—
—
—
cases:2.34%
controls:0.65%
cases:4.03%
controls:1.24%
13
56
366
3734
9
21
370
3769
—
—
—
8
23
334
3527
10
32
238
2548
Recurrent depressive disorder, current episode severe without psychotic symptoms
F33.2 [45547705]
F33.2 [45547705]
1.5e+00
—
—
—
—
—
1.6e+00
cases:2.37%
controls:0.55%
—
—
—
—
—
—
—
—
—
—
cases:2.82%
controls:0.58%
9
21
370
3769
—
—
—
—
—
7
15
241
2565
Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2865-4 [3015322]
2865-4 [3015322]
1.5e+00
9.8e-01
—
—
—
—
6.2e-01
cases:4.22%
controls:1.00%
cases:1.32%
controls:0.50%
—
—
—
—
—
—
—
—
cases:2.42%
controls:1.32%
16
38
363
3752
5
19
374
3771
—
—
—
—
6
34
242
2546
Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2874-6 [3023465]
2874-6 [3023465]
1.5e+00
1.0e+00
—
—
—
—
1.1e+00
cases:4.22%
controls:1.00%
cases:1.32%
controls:0.47%
—
—
—
—
—
—
—
—
cases:2.82%
controls:0.97%
16
38
363
3752
5
18
374
3772
—
—
—
—
7
25
241
2555
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
5802-4 [3021601]
2.6e-01
4.5e-01
5.7e-01
—
1.4e+00
2.3e-01
2.9e-01
cases:20.32%
controls:16.39%
cases:11.87%
controls:7.89%
cases:1.85%
controls:1.06%
—
—
cases:4.77%
controls:1.19%
cases:11.11%
controls:9.04%
cases:24.60%
controls:19.61%
77
621
302
3169
45
299
334
3491
7
40
372
3750
—
18
45
359
3726
38
321
304
3229
61
506
187
2074
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
30248-9 [3015399]
5.9e-01
8.1e-01
9.7e-01
—
—
5.6e-01
3.8e-01
cases:13.98%
controls:8.28%
cases:7.92%
controls:3.67%
cases:1.58%
controls:0.61%
—
—
—
—
cases:6.14%
controls:3.61%
cases:12.50%
controls:8.91%
53
314
326
3476
30
139
349
3651
6
23
373
3767
—
—
21
128
321
3422
31
230
217
2350
IgE [Units/volume] in Serum or Plasma
19113-0 [3005322]
19113-0 [3005322]
1.4e+00
1.2e+00
—
—
—
1.3e+00
4.3e-01
cases:5.01%
controls:1.29%
cases:1.58%
controls:0.50%
—
—
—
—
—
—
cases:1.75%
controls:0.48%
cases:2.02%
controls:1.32%
19
49
360
3741
6
19
373
3771
—
—
—
6
17
336
3533
5
34
243
2546
Tissue transglutaminase IgG Ab [Units/volume] in Serum
32998-7 [3046870]
32998-7 [3046870]
1.4e+00
—
—
—
—
—
6.8e-01
cases:2.90%
controls:0.74%
—
—
—
—
—
—
—
—
—
—
cases:3.23%
controls:1.67%
11
28
368
3762
—
—
—
—
—
8
43
240
2537
Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32730-4 [3043723]
32730-4 [3043723]
1.3e+00
8.7e-01
—
—
—
—
6.9e-01
cases:4.22%
controls:1.13%
cases:1.32%
controls:0.55%
—
—
—
—
—
—
—
—
cases:2.82%
controls:1.43%
16
43
363
3747
5
21
374
3769
—
—
—
—
7
37
241
2543
Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32731-2 [3043747]
32731-2 [3043747]
1.3e+00
9.2e-01
—
—
—
—
6.9e-01
cases:4.22%
controls:1.13%
cases:1.32%
controls:0.53%
—
—
—
—
—
—
—
—
cases:2.82%
controls:1.43%
16
43
363
3747
5
20
374
3770
—
—
—
—
7
37
241
2543
Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2868-8 [3005229]
2868-8 [3005229]
1.3e+00
8.7e-01
—
—
—
—
6.9e-01
cases:4.22%
controls:1.13%
cases:1.32%
controls:0.55%
—
—
—
—
—
—
—
—
cases:2.82%
controls:1.43%
16
43
363
3747
5
21
374
3769
—
—
—
—
7
37
241
2543
General anesthesia, balanced
WX408 [2001310808]
WX408 [2001310808]
5.5e-01
—
—
—
—
—
1.3e+00
cases:6.86%
controls:4.09%
—
—
—
—
—
—
—
—
—
—
cases:4.44%
controls:1.20%
26
155
353
3635
—
—
—
—
—
11
31
237
2549
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
1798-8 [3016771]
5.4e-01
7.6e-01
—
—
1.5e+00
3.6e-01
3.9e-01
cases:14.51%
controls:9.02%
cases:6.86%
controls:3.32%
—
—
—
—
cases:2.12%
controls:0.50%
cases:4.68%
controls:3.30%
cases:12.10%
controls:8.53%
55
342
324
3448
26
126
353
3664
—
—
8
19
369
3752
16
117
326
3433
30
220
218
2360
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
24357-6 [3037467]
3.0e-01
4.5e-01
1.7e-01
—
1.3e+00
3.2e-01
3.3e-01
cases:32.45%
controls:26.17%
cases:16.62%
controls:11.27%
cases:1.85%
controls:1.56%
—
—
cases:5.04%
controls:1.43%
cases:14.33%
controls:10.87%
cases:28.63%
controls:22.33%
123
992
256
2798
63
427
316
3363
7
59
372
3731
—
19
54
358
3717
49
386
293
3164
71
576
177
2004
Examination of eyes and vision
Z01.0 [45566391]
Z01.0 [45566391]
2.9e-01
9.1e-01
—
—
—
1.3e+00
2.7e-01
cases:3.96%
controls:2.98%
cases:2.90%
controls:1.19%
—
—
—
—
—
—
cases:4.09%
controls:1.15%
cases:4.84%
controls:3.72%
15
113
364
3677
11
45
368
3745
—
—
—
14
41
328
3509
12
96
236
2484
Complicated extraction of tooth
EBA05 [2001301924]
EBA05 [2001301924]
2.9e-01
1.3e+00
—
—
—
—
3.8e-01
cases:4.22%
controls:3.19%
cases:3.17%
controls:0.90%
—
—
—
—
—
—
—
—
cases:5.24%
controls:3.64%
16
121
363
3669
12
34
367
3756
—
—
—
—
13
94
235
2486
Predominantly allergic asthma
J45.0 [45557624]
J45.0 [45557624]
1.3e+00
1.5e+00
—
1.0e+50
—
1.7e+00
1.3e+00
cases:4.22%
controls:1.21%
cases:2.11%
controls:0.47%
—
—
cases:1.32%
controls:0.00%
—
—
cases:2.05%
controls:0.37%
cases:3.23%
controls:0.89%
16
46
363
3744
8
18
371
3772
—
5
0
374
3790
—
7
13
335
3537
8
23
240
2557
salbutamol; inhalant
R03AC02 [21603256]
R03AC02 [21603256]
3.9e-01
6.6e-01
7.8e-01
—
6.3e-01
3.9e-01
5.9e-01
cases:22.69%
controls:16.52%
cases:13.98%
controls:7.78%
cases:3.17%
controls:1.48%
—
—
cases:2.12%
controls:1.14%
cases:11.70%
controls:8.23%
cases:23.39%
controls:14.42%
86
626
293
3164
53
295
326
3495
12
56
367
3734
—
8
43
369
3728
40
292
302
3258
58
372
190
2208
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
2324-2 [3026910]
4.7e-01
7.6e-01
—
—
3.4e-01
4.1e-01
1.1e-01
cases:31.66%
controls:22.40%
cases:17.94%
controls:9.26%
—
—
—
—
cases:1.59%
controls:1.14%
cases:13.74%
controls:9.55%
cases:23.39%
controls:21.43%
120
849
259
2941
68
351
311
3439
—
—
6
43
371
3728
47
339
295
3211
58
553
190
2027
Proteinase 3 Ab [Units/volume] in Serum
6968-2 [3009445]
6968-2 [3009445]
1.2e+00
—
—
—
—
—
—
cases:3.69%
controls:1.11%
—
—
—
—
—
—
—
—
—
—
—
—
14
42
365
3748
—
—
—
—
—
—
General psychiatric examination, not elsewhere classified
Z00.4 [45605094]
Z00.4 [45605094]
1.2e+00
—
—
—
—
1.6e+00
4.6e-01
cases:3.69%
controls:1.11%
—
—
—
—
—
—
—
—
cases:2.05%
controls:0.42%
cases:2.02%
controls:1.28%
14
42
365
3748
—
—
—
—
7
15
335
3535
5
33
243
2547
venlafaxine; oral
N06AX16 [21604745]
N06AX16 [21604745]
6.0e-01
7.1e-01
—
—
—
1.1e+00
1.2e+00
cases:3.69%
controls:2.06%
cases:2.64%
controls:1.32%
—
—
—
—
—
—
cases:3.80%
controls:1.35%
cases:6.85%
controls:2.13%
14
78
365
3712
10
50
369
3740
—
—
—
13
48
329
3502
17
55
231
2525
spironolactone; oral
C03DA01 [21601534]
C03DA01 [21601534]
1.2e+00
8.6e-01
6.2e-01
—
1.4e+00
8.4e-01
7.8e-01
cases:6.86%
controls:2.14%
cases:4.49%
controls:1.95%
cases:1.32%
controls:0.71%
—
—
cases:2.12%
controls:0.56%
cases:4.39%
controls:1.94%
cases:5.65%
controls:2.67%
26
81
353
3709
17
74
362
3716
5
27
374
3763
—
8
21
369
3750
15
69
327
3481
14
69
234
2511
Haptoglobin [Mass/volume] in Serum or Plasma
4542-7 [3012336]
4542-7 [3012336]
1.2e+00
—
—
—
—
1.6e+00
—
cases:4.22%
controls:1.29%
—
—
—
—
—
—
—
—
cases:1.75%
controls:0.37%
—
—
16
49
363
3741
—
—
—
—
6
13
336
3537
—
Epistaxis
R04.0 [45606791]
R04.0 [45606791]
1.2e+00
—
—
—
—
—
5.6e-01
cases:3.43%
controls:1.06%
—
—
—
—
—
—
—
—
—
—
cases:2.02%
controls:1.16%
13
40
366
3750
—
—
—
—
—
5
30
243
2550
amitriptyline and psycholeptics
N06CA01 [21604789]
N06CA01 [21604789]
1.2e+00
—
—
—
—
—
1.4e+00
cases:3.43%
controls:1.06%
—
—
—
—
—
—
—
—
—
—
cases:2.42%
controls:0.62%
13
40
366
3750
—
—
—
—
—
6
16
242
2564
Bilateral
ZXA10 [2001311348]
ZXA10 [2001311348]
-4.0e-01
—
—
—
—
—
1.2e+00
cases:1.85%
controls:2.74%
—
—
—
—
—
—
—
—
—
—
cases:6.05%
controls:1.90%
7
104
372
3686
—
—
—
—
—
15
49
233
2531
potassium chloride; oral
A12BA01 [21600877]
A12BA01 [21600877]
6.0e-01
8.0e-01
—
—
—
1.1e+00
1.2e+00
cases:3.96%
controls:2.22%
cases:2.90%
controls:1.32%
—
—
—
—
—
—
cases:3.51%
controls:1.21%
cases:6.85%
controls:2.17%
15
84
364
3706
11
50
368
3740
—
—
—
12
43
330
3507
17
56
231
2524
diclofenac; oral, parenteral, rectal
M01AB05 [21603945]
M01AB05 [21603945]
4.9e-01
6.1e-01
—
—
7.8e-01
4.7e-01
6.9e-01
cases:22.16%
controls:14.91%
cases:7.65%
controls:4.33%
—
—
—
—
cases:1.33%
controls:0.61%
cases:7.31%
controls:4.68%
cases:22.18%
controls:12.52%
84
565
295
3225
29
164
350
3626
—
—
5
23
372
3748
25
166
317
3384
55
323
193
2257
More than one and less than three hours
ZXE10 [2001311401]
ZXE10 [2001311401]
4.2e-01
1.1e+00
—
1.0e+50
—
1.0e+00
1.2e+00
cases:7.92%
controls:5.36%
cases:2.90%
controls:1.00%
—
—
cases:1.58%
controls:0.00%
—
—
cases:2.05%
controls:0.76%
cases:7.26%
controls:2.36%
30
203
349
3587
11
38
368
3752
—
6
0
373
3790
—
7
27
335
3523
18
61
230
2519
Administration of medicine
SPAT1254 [2001700355]
SPAT1254 [2001700355]
5.7e-01
1.0e+00
1.3e+00
—
1.1e+00
1.2e+00
4.2e-01
cases:4.49%
controls:2.59%
cases:2.90%
controls:1.06%
cases:1.85%
controls:0.53%
—
—
cases:1.59%
controls:0.53%
cases:4.39%
controls:1.41%
cases:4.03%
controls:2.67%
17
98
362
3692
11
40
368
3750
7
20
372
3770
—
6
20
371
3751
15
50
327
3500
10
69
238
2511
Ferritin [Mass/volume] in Serum or Plasma
2276-4 [3001122]
2276-4 [3001122]
4.9e-01
6.6e-01
8.9e-01
—
8.5e-01
3.7e-01
4.5e-01
cases:20.84%
controls:13.88%
cases:13.46%
controls:7.44%
cases:3.17%
controls:1.32%
—
—
cases:2.39%
controls:1.03%
cases:11.99%
controls:8.59%
cases:25.00%
controls:17.52%
79
526
300
3264
51
282
328
3508
12
50
367
3740
—
9
39
368
3732
41
305
301
3245
62
452
186
2128
One hour or less
ZXE00 [2001311394]
ZXE00 [2001311394]
3.6e-01
1.1e+00
—
1.0e+50
—
6.4e-01
8.2e-01
cases:8.71%
controls:6.25%
cases:3.69%
controls:1.24%
—
—
cases:1.32%
controls:0.00%
—
—
cases:1.75%
controls:0.93%
cases:6.45%
controls:2.95%
33
237
346
3553
14
47
365
3743
—
5
0
374
3790
—
6
33
336
3517
16
76
232
2504
Parathyrin.intact [Mass/volume] in Serum or Plasma
2731-8 [3000067]
2731-8 [3000067]
1.1e+00
8.6e-01
—
—
2.1e+00
7.7e-01
7.2e-01
cases:6.60%
controls:2.30%
cases:2.64%
controls:1.13%
—
—
—
—
cases:1.33%
controls:0.16%
cases:2.34%
controls:1.10%
cases:4.44%
controls:2.21%
25
87
354
3703
10
43
369
3747
—
—
5
6
372
3765
8
39
334
3511
11
57
237
2523
Knee X-ray examination without contrast
NG1AA [2001308049]
NG1AA [2001308049]
8.0e-01
—
—
1.0e+50
—
—
1.1e+00
cases:4.75%
controls:2.19%
—
—
—
—
cases:2.64%
controls:0.00%
—
—
—
—
cases:5.24%
controls:1.82%
18
83
361
3707
—
—
10
0
369
3790
—
—
13
47
235
2533
Standard cardiac ultrasound examination
FM1AE [2001303278]
FM1AE [2001303278]
1.1e+00
4.9e-01
—
—
—
6.2e-01
8.6e-01
cases:8.44%
controls:3.01%
cases:1.85%
controls:1.13%
—
—
—
—
—
—
cases:1.46%
controls:0.79%
cases:5.65%
controls:2.48%
32
114
347
3676
7
43
372
3747
—
—
—
5
28
337
3522
14
64
234
2516
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
121
557
2.72
17.05
4.5
2.9
2.85
2.77
e6/l
0.02
58
269
95
403
2.81
15.52
2.3
1.8
—
—
—
0
0
60
195
3.46
15.49
2.0
1.7
—
—
—
0
0
123
598
2.56
15.28
4.6
2.8
0.79
0.85
e6/l
0.09
58
305
97
422
2.74
15.06
2.3
1.8
—
—
—
0
0
88
374
2.76
14.23
7.9
10.0
0.10
1.03
mmol/l
1.27
77
312
224
1463
2.28
13.79
22.2
13.1
1.29
1.21
inr
1.30
187
1199
110
552
2.39
12.43
2.3
1.9
—
—
—
0
0
289
2175
2.35
11.68
6.7
4.7
5869.71
993.47
e6/l
—
7
40
178
1119
2.11
11.35
5.0
3.3
28.27
101.49
e6/l
0.65
134
845
76
334
2.59
11.32
3.6
2.5
75.79
32.36
u/l
0.42
68
284
77
343
2.56
11.15
5.6
4.5
1.71
1.86
mmol/l
0.12
72
291
57
218
2.90
11.09
2.4
3.2
190.67
182.12
ng/l
0.06
49
202
34
94
3.87
11.06
2.6
2.3
0.01
0.00
g/l
0.49
34
84
94
461
2.38
11.05
3.9
2.3
21.89
22.93
%
0.27
89
438
35
99
3.79
11.03
2.5
2.2
0.07
0.05
g/l
0.13
35
92
99
498
2.33
10.97
3.8
2.3
2.16
2.32
g/l
1.65
93
464
185
1196
2.06
10.79
4.4
3.4
28.61
32.18
u/l
1.08
179
1141
225
1564
2.07
10.72
4.1
2.8
—
—
estimate
—
0
0
93
461
2.34
10.63
7.0
7.5
103.27
103.98
mmol/l
0.48
93
461
143
847
2.10
10.50
2.8
2.2
2.27
2.91
mg/l
2.82
126
738
261
1943
2.08
9.99
8.9
5.6
6.65
6.65
mmol/l
0.02
251
1834
210
1448
2.00
9.96
7.1
5.0
34.84
35.94
g/l
2.20
203
1370
114
630
2.15
9.94
5.2
3.9
148.60
330.31
ng/l
0.94
93
470
135
797
2.07
9.89
3.9
2.4
—
—
—
0
0
225
1597
1.99
9.73
4.2
3.0
137.05
109.71
ug/l
1.22
219
1500
155
967
2.01
9.72
5.0
3.1
0.48
0.37
e6/l
0.23
106
697
229
1639
1.99
9.63
11.3
7.6
1.21
1.21
mmol/l
0.44
217
1430
100
540
2.15
9.17
4.0
2.3
11.52
13.52
umol/l
1.91
94
504
38
129
3.16
9.06
1.4
1.3
—
—
—
0
0
81
407
2.26
8.85
4.5
3.7
5.06
7.00
umol/l
1.75
75
363
138
851
1.97
8.76
3.3
3.0
362.53
340.81
umol/l
1.18
125
758
85
439
2.20
8.67
9.6
6.3
1.14
1.05
mmol/l
1.48
79
404
55
240
2.51
8.21
5.3
3.9
91.12
80.19
ng/l
0.55
48
215
252
1919
1.92
8.21
12.5
10.1
4.56
4.08
e9/l
1.88
221
1671
235
1752
1.89
8.15
7.0
7.0
10.87
11.20
umol/l
0.27
228
1666
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
30
94
3.38
8.13
2.6
3.5
0.31
0.34
iu/ml
0.20
13
51
38
139
2.93
7.97
2.3
2.0
1.40
1.44
g/l
0.09
32
123
204
1482
1.81
7.42
10.4
7.1
1.20
1.21
mmol/l
0.76
197
1381
151
1002
1.84
7.41
3.3
2.1
228.45
350.59
u/l
0.42
146
957
53
240
2.40
7.30
2.3
1.7
—
—
—
0
0
124
780
1.87
7.17
2.2
1.9
1.05
1.43
mg/l
1.01
102
616
232
1793
1.75
6.45
4.9
3.8
0.00
7.88
estimate
0.80
41
385
230
1775
1.74
6.41
4.9
3.8
0.00
0.00
estimate
-0.00
42
382
233
1805
1.75
6.40
4.9
3.9
0.11
0.83
estimate
0.41
36
360
141
956
1.75
6.20
2.1
1.6
19.25
20.60
nmol/l
0.53
127
823
359
3234
2.83
5.92
31.4
15.6
23.23
23.41
mg/l
0.04
331
2672
27
97
2.92
5.86
2.8
3.3
39.50
50.43
mg/l
0.19
27
83
27
97
2.92
5.86
2.9
3.3
57.91
117.30
mg/l
0.46
27
83
193
1446
1.68
5.77
2.7
2.0
94.05
96.31
pmol/l
0.28
112
757
46
223
2.21
5.40
3.0
3.8
120.70
130.06
g/l
1.64
46
218
195
1489
1.63
5.24
3.1
2.5
73.99
74.92
nmol/l
0.17
183
1352
295
2510
1.77
5.17
11.3
8.2
77.50
78.93
u/l
0.30
290
2382
75
444
1.86
5.08
2.1
1.8
1.44
1.44
%
0.03
69
396
18
56
3.32
4.96
1.2
1.4
—
—
—
0
0
18
56
3.32
4.96
1.2
1.4
—
—
—
0
0
21
72
3.03
4.95
1.9
1.5
—
—
—
0
0
38
177
2.27
4.91
1.5
1.4
—
—
—
0
0
343
3077
2.12
4.88
28.6
14.9
81.70
83.64
ml/min/173m2
0.74
319
2837
319
2796
1.85
4.82
39.2
19.8
330.79
332.84
g/l
3.12
319
2784
24
91
2.75
4.75
3.0
2.9
2.09
3.17
ratio
0.42
13
51
83
518
1.77
4.71
1.7
1.7
1091.33
1182.98
nmol/l
0.44
72
400
288
2460
1.69
4.67
5.7
4.2
14.56
11.01
mm/h
3.20
277
2307
23
86
2.78
4.67
3.4
3.6
0.10
1.91
index
3.03
11
55
135
970
1.61
4.48
3.7
3.3
1820.28
1204.59
ng/l
0.78
127
820
273
2317
1.62
4.36
4.2
3.5
44.60
47.19
u/l
0.26
264
2196
141
1038
1.57
4.16
4.8
4.1
20.43
10.95
mg/mmol
0.70
94
663
55
314
1.88
4.15
3.9
3.4
—
—
—
0
0
148
1115
1.53
3.88
4.5
3.3
6.93
7.90
mmol/l
1.69
125
956
21
83
2.62
3.87
1.3
1.5
10130.80
10260.92
e6/l
—
10
59
252
2161
1.49
3.31
3.8
3.4
—
—
—
0
0
90
627
1.57
3.28
1.4
1.3
48.46
34.55
iu/ml
0.30
26
199
6
7
8.68
3.27
2.3
2.6
161.33
131.00
%
—
6
7
7
12
5.92
3.03
1.3
1.1
—
—
—
0
0
329
3024
1.63
2.81
5.7
5.3
1.79
1.91
mu/l
1.10
311
2810
5
6
8.42
2.75
1.0
1.3
—
—
—
0
0
9
24
3.81
2.69
1.9
2.3
—
—
—
0
0
23
114
2.08
2.62
2.8
3.1
—
—
—
0
0
7
15
4.73
2.61
2.6
2.7
537.86
822.33
u/ml
—
7
15
346
3235
1.74
2.59
5.8
5.5
2.62
2.70
mmol/l
1.00
333
3027
90
665
1.46
2.45
2.9
2.8
2.46
2.45
mmol/l
0.31
81
593
360
3415
1.94
2.43
17.0
11.7
25.65
26.65
u/l
0.60
355
3337
28
155
1.87
2.37
4.5
3.5
25.95
25.09
mmol/l
0.57
28
150
8
23
3.53
2.28
2.1
1.5
—
—
—
0
0
8
23
3.53
2.28
2.5
2.4
—
—
—
0
0
6
13
4.67
2.28
1.2
1.1
—
—
—
0
0
11
41
2.73
2.22
1.5
1.5
—
—
—
0
0
141
1150
1.36
2.15
3.2
3.3
2.32
2.35
mmol/l
1.78
132
1046
18
88
2.10
2.15
1.8
1.4
—
—
—
0
0
20
103
1.99
2.09
1.6
1.2
—
—
—
0
0
324
3016
1.49
2.08
7.3
6.2
40.09
39.17
mmol/mol
0.85
314
2865
6
15
4.05
2.04
1.2
1.4
—
—
—
0
0
330
3086
1.51
2.04
4.9
4.8
6.06
5.91
mmol/l
0.90
310
2854
338
3178
1.55
2.02
5.0
4.8
1.39
1.45
mmol/l
2.35
322
2970
109
861
1.37
2.01
1.4
1.3
1.14
1.57
u/ml
0.40
26
234
82
617
1.42
2.01
1.5
1.8
77333774.21
43160366.52
pmol/l
0.17
75
519
25
142
1.81
1.98
1.2
1.5
200.00
302.76
miu/ml
0.91
12
75
12
51
2.40
1.97
1.1
1.2
1.52
1.48
g/l
0.17
12
46
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
5
11
4.59
1.94
3.4
2.0
181.60
116.55
%
—
5
11
32
201
1.65
1.81
3.1
3.6
1.73
1.54
mmol/l
0.14
23
156
83
638
1.38
1.80
2.5
3.1
0.73
0.77
ug/l
0.14
47
398
337
3185
1.49
1.76
5.2
5.0
4.50
4.61
mmol/l
1.08
323
2988
147
1238
1.30
1.73
4.4
3.8
31.96
42.34
ng/l
0.53
93
864
11
48
2.33
1.72
1.1
1.1
—
—
—
0
0
10
40
2.54
1.68
1.6
1.3
—
—
—
0
0
75
574
1.38
1.67
1.4
1.3
4.10
10.60
u/ml
1.15
21
227
277
2544
1.32
1.66
4.4
4.3
14.55
14.74
pmol/l
0.64
263
2341
5
14
3.60
1.62
2.8
3.6
178.20
217.36
u/l
—
5
14
7
26
2.72
1.58
1.4
1.3
0.69
6.31
u/ml
—
7
14
30
194
1.59
1.54
2.2
3.6
4.51
4.63
pmol/l
0.24
30
170
14
72
1.98
1.50
1.4
1.3
—
—
—
0
0
101
822
1.31
1.50
3.5
4.4
25.66
21.57
%
1.30
33
380
7
28
2.53
1.46
1.1
1.2
—
—
—
0
0
6
22
2.75
1.44
2.5
5.7
68.67
96.09
%
—
6
22
15
81
1.89
1.42
1.5
1.4
—
—
—
0
0
9
40
2.28
1.41
3.7
3.7
—
—
—
0
0
20
119
1.72
1.40
2.0
1.5
—
—
—
0
0
7
29
2.44
1.40
1.1
1.1
—
—
—
0
0
11
53
2.11
1.40
1.6
1.1
—
50.67
—
0
9
5
17
2.97
1.36
1.8
1.4
—
—
—
0
0
14
75
1.90
1.36
1.7
1.4
123.50
151.97
au/ml
—
6
22
18
105
1.75
1.35
1.3
1.4
—
—
—
0
0
0
37
0.00
1.35
0.0
1.5
—
—
—
0
0
0
37
0.00
1.35
0.0
1.5
—
—
—
0
0
13
71
1.86
1.21
1.9
1.8
—
—
—
0
0
15
86
1.77
1.20
1.3
1.3
236.86
250.02
u/ml
—
7
46
96
799
1.27
1.19
5.2
3.8
1.02
1.02
kg/l
1.54
76
536
11
57
1.96
1.18
2.0
1.2
3.80
2.34
u/ml
—
5
29
8
39
2.07
1.16
1.5
1.2
—
—
—
0
0
22
328
0.65
1.15
10.1
7.0
—
—
—
0
0
5
20
2.52
1.15
2.4
1.7
83.60
75.90
umol/l
—
5
20
5
20
2.52
1.15
1.4
2.0
—
—
—
0
0
5
20
2.52
1.15
1.0
1.1
—
—
—
0
0
5
20
2.52
1.15
1.4
2.0
—
—
—
0
0
0
36
0.00
1.14
0.0
1.5
—
—
—
0
0
18
111
1.65
1.14
1.1
1.3
—
—
—
0
0
36
261
1.42
1.12
4.1
2.7
70.27
66.32
ml/min/173m2
0.30
11
114
10
51
1.99
1.12
1.1
1.1
0.07
0.02
u/ml
—
5
16
22
144
1.56
1.11
3.6
2.2
15136.83
4217.69
u/l
0.52
11
50
318
3031
1.29
1.09
4.3
4.2
1.33
1.28
mmol/l
0.60
301
2809
19
285
0.65
1.04
1.7
1.8
3.76
3.45
mmol/l
0.96
13
205
5
22
2.29
1.03
2.0
3.8
96.60
154.41
nmol/l
—
5
22
10
53
1.91
1.02
2.1
1.2
12.40
2.90
u/ml
—
5
21
10
53
1.91
1.02
1.1
1.2
—
—
—
0
0
15
92
1.66
0.98
1.1
1.3
—
—
—
0
0
5
23
2.19
0.98
1.2
1.0
—
—
—
0
0
153
1365
1.20
0.98
2.2
1.9
1.43
1.35
mmol/l
0.45
137
1173
59
477
1.28
0.94
3.0
2.3
—
—
—
0
0
6
27
2.24
0.94
1.8
1.5
—
—
—
0
0
26
185
1.44
0.92
2.2
1.5
0.41
0.35
mg/l
0.23
15
77
116
1024
1.19
0.82
4.6
5.1
4.98
2.46
ug/l
0.32
106
925
6
34
1.78
0.76
1.0
1.1
—
—
—
0
0
5
24
2.10
0.75
1.8
2.0
8.34
7.42
mmol/l
—
5
24
7
38
1.86
0.74
1.0
1.1
—
—
—
0
0
36
284
1.30
0.71
2.0
2.1
—
—
—
0
0
113
1008
1.17
0.70
4.2
3.2
0.00
0.09
estimate
0.55
34
304
7
41
1.72
0.70
1.0
1.1
—
—
—
0
0
9
59
1.54
0.69
5.9
3.0
21.10
8.37
pmol/l
—
9
59
19
137
1.41
0.66
2.5
1.9
—
—
—
0
0
30
234
1.31
0.65
1.8
2.0
—
—
—
0
0
13
87
1.51
0.64
1.0
1.4
3.72
3.78
mmol/l
0.08
13
80
25
191
1.33
0.62
1.0
1.0
—
—
—
0
0
5
30
1.68
0.61
1.6
1.5
94.24
162.82
pmol/l
—
5
30
5
30
1.68
0.61
6.2
1.6
—
—
—
0
0
30
375
0.78
0.60
5.1
4.6
29.64
31.18
%
0.49
22
249
148
1362
1.14
0.60
4.8
3.7
0.00
0.02
estimate
1.08
35
323
11
72
1.54
0.59
4.4
4.4
15.86
27.96
mg/l
1.42
11
52
42
503
0.81
0.58
1.2
1.5
—
—
—
0
0
52
441
1.21
0.58
2.9
2.2
—
—
—
0
0
12
82
1.48
0.55
1.2
1.8
—
—
—
0
0
14
100
1.42
0.52
1.5
1.6
—
—
—
0
0
109
993
1.14
0.51
4.7
4.0
0.00
0.02
estimate
0.96
37
359
14
101
1.40
0.50
1.5
1.6
1.32
1.18
ratio
—
8
65
14
101
1.40
0.50
1.5
1.6
0.99
1.16
ratio
—
8
65
14
101
1.40
0.50
1.5
1.6
0.80
0.95
ratio
—
8
65
20
154
1.32
0.49
1.9
2.3
36.00
39.14
u/l
0.37
20
141
23
182
1.28
0.47
1.5
1.3
—
—
—
0
0
10
68
1.48
0.47
1.1
1.1
16.56
13.33
au/ml
—
5
20
7
48
1.47
0.47
1.3
1.3
—
—
—
0
0
29
238
1.24
0.45
1.6
1.3
160.58
137.41
u/ml
0.12
11
91
5
32
1.57
0.42
1.0
1.0
—
—
—
0
0
8
58
1.39
0.41
1.3
1.2
25.73
21.23
u/l
—
8
47
8
58
1.39
0.41
1.4
1.5
—
—
—
0
0
5
33
1.52
0.41
5.4
1.9
13.42
13.32
%
—
5
33
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
0
15
0.00
0.41
0.0
2.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
0
16
0.00
0.41
0.0
2.1
—
—
—
0
0
0
16
0.00
0.41
0.0
2.1
—
—
—
0
0
0
16
0.00
0.41
0.0
2.1
—
—
—
0
0
0
16
0.00
0.41
0.0
2.1
—
—
—
0
0
17
133
1.29
0.39
1.6
1.8
38.06
39.84
nmol/l
0.14
17
128
33
385
0.84
0.38
1.8
2.0
3.67
3.54
ratio
0.30
28
307
5
37
1.36
0.37
1.0
1.2
—
—
—
0
0
6
42
1.44
0.35
1.2
1.0
—
—
—
0
0
35
303
1.17
0.34
2.6
4.6
3.93
21.40
ug/l
0.66
28
246
6
87
0.68
0.33
1.0
1.1
—
2.73
—
0
10
6
87
0.68
0.33
1.2
1.8
—
—
—
0
0
6
47
1.28
0.32
1.2
1.4
—
—
—
0
0
13
101
1.30
0.32
2.0
1.7
206.15
224.53
pmol/l
0.44
13
93
7
99
0.70
0.31
1.1
1.6
—
—
—
0
0
78
720
1.10
0.30
1.9
1.6
—
—
—
0
0
12
93
1.30
0.30
1.0
1.3
—
—
—
0
0
7
93
0.75
0.22
1.1
1.4
—
—
—
0
0
10
79
1.27
0.22
1.6
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
2.0
—
43.48
—
0
11
0
10
0.00
0.21
0.0
1.0
—
0.06
—
0
5
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
0.01
—
0
5
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
2.85
—
0
7
0
14
0.00
0.20
0.0
2.2
—
—
—
0
0
0
14
0.00
0.20
0.0
2.2
—
—
—
0
0
6
53
1.13
0.19
1.5
1.2
—
—
—
0
0
16
138
1.17
0.17
1.7
1.6
439.02
297.51
mu/l
0.37
16
130
13
111
1.18
0.16
1.9
2.0
—
—
—
0
0
6
78
0.77
0.15
1.8
1.9
—
—
—
0
0
10
83
1.21
0.15
1.2
1.2
—
54.44
—
0
9
9
83
1.09
0.14
1.0
1.3
—
1.00
—
0
8
12
104
1.16
0.12
1.1
1.2
—
—
—
0
0
12
105
1.15
0.11
1.9
1.8
—
—
—
0
0
12
105
1.15
0.11
1.1
1.2
—
—
—
0
0
11
96
1.15
0.10
1.7
1.6
—
—
—
0
0
5
61
0.82
0.08
1.6
1.4
0.84
0.36
nmol/l
—
5
47
5
60
0.83
0.08
1.0
1.1
—
2.22
—
0
10
5
60
0.83
0.08
1.2
1.4
—
231.43
—
0
7
5
60
0.83
0.08
1.2
1.3
—
—
—
0
0
10
88
1.14
0.08
1.1
1.2
—
—
—
0
0
7
66
1.06
0.08
1.1
1.5
—
—
—
0
0
14
129
1.09
0.05
1.4
1.5
—
—
—
0
0
26
248
1.05
0.05
1.7
1.5
—
—
—
0
0
11
103
1.07
0.02
1.7
1.7
—
—
—
0
0
13
136
0.95
0.00
1.1
1.2
0.84
0.90
g/l
0.60
13
136
0
5
0.00
-0.00
0.0
1.0
—
0.02
—
0
5
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
12.71
—
0
7
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
6
66
0.91
-0.00
1.2
1.8
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.9
—
35.25
—
0
8
0
6
0.00
-0.00
0.0
1.0
—
40.67
—
0
6
13
130
1.00
-0.00
1.1
1.1
1.50
1.54
g/l
0.24
13
130
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
7
69
1.01
-0.00
1.7
1.5
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
5
51
0.98
-0.00
1.2
1.5
28.58
23.82
u/l
—
5
46
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
4.0
—
57.22
—
0
5
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: ST19_OTHER_INJURI_LOWER_LIMB_LEVEL_UNSPE – Other injuries of lower limb, level unspecified
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).